Raras
Buscar doenças, sintomas, genes...
Doença do transporte de aminoácidos
ORPHA:79166CID-10 · E72.0CID-11 · 5C60DOENÇA RARA

Vitamina D faz parte de um grupo de secosteroides solúveis em gordura responsáveis por aumentar a absorção intestinal de cálcio, magnésio e fosfato e por muitos outros efeitos biológicos. Em humanos, os compostos mais importantes neste grupo são a vitamina D3 (também conhecida como colecalciferol) e a vitamina D2 (ergocalciferol).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara que afeta o transporte e absorção de aminoácidos, manifestando-se com problemas oculares (retinopatia, oftalmoplegia), auditivos, ceratocone e alterações metabólicas como hiperinsulinemia.

🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E72.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (7)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)nutritional
0301070040
Atendimento em reabilitação — doenças raras
+1 outros procedimentos
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
91 sintomas
👁️
Olhos
90 sintomas
🫘
Rins
37 sintomas
🦴
Ossos e articulações
33 sintomas
📏
Crescimento
27 sintomas
😀
Face
24 sintomas

+ 253 sintomas em outras categorias

Características mais comuns

Megacariocitopenia
Morfologia vascular retiniana anormal
Anormalidade da pigmentação retiniana
Oftalmoplegia
Perda do segmento externo do fotorreceptor na OCT macular
Resposta central anormal do eletrorretinograma multifocal
639sintomas
Sem dados (639)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 639 características clínicas mais associadas, ordenadas por frequência.

MegacariocitopeniaMegakaryocytopenia
Morfologia vascular retiniana anormalAbnormal retinal vascular morphology
Anormalidade da pigmentação retinianaAbnormality of retinal pigmentation
OftalmoplegiaOphthalmoplegia
Perda do segmento externo do fotorreceptor na OCT macularPhotoreceptor outer segment loss on macular OCT

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa9
Últimos 10 anos200publicações
Pico202431 papers
Linha do tempo
20202017Hoje · 2026📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

83 genes identificados com associação a esta condição.

PRPH2Peripherin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure (By similarity). Required for the maintenance of retinal outer nuclear layer thickness (By similarity). Required for the correct development and organization of the photoreceptor inner segment (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.3 TPM
Ovário
6.8 TPM
Cervix Ectocervix
5.7 TPM
Pituitária
5.3 TPM
Músculo esquelético
5.0 TPM
OUTRAS DOENÇAS (13)
retinitis pigmentosa 7vitelliform macular dystrophy 3fundus albipunctatuschoroidal dystrophy, central areolar 2
HGNC:9942UniProt:P23942
CLTRNCollectrinCandidate gene tested inTolerante
FUNÇÃO

Plays an important role in amino acid transport by acting as binding partner of amino acid transporters SLC6A18 and SLC6A19, regulating their trafficking on the cell surface and their amino acid transporter activity (By similarity). May also play a role in trafficking of amino acid transporters SLC3A1 and SLC7A9 to the renal cortical cell membrane (By similarity). Regulator of SNARE complex function (PubMed:16330323). Stimulator of beta cell replication (PubMed:16330323)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Insulin processing
VIAS REACTOME (1)
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
Hartnup disease
HGNC:29437UniProt:Q9HBJ8
PREPLProlyl endopeptidase-likeCandidate gene tested inTolerante
FUNÇÃO

Serine peptidase whose precise substrate specificity remains unclear (PubMed:16143824, PubMed:16385448, PubMed:28726805). Does not cleave peptides after a arginine or lysine residue (PubMed:16143824). Regulates trans-Golgi network morphology and sorting by regulating the membrane binding of the AP-1 complex (PubMed:23321636). May play a role in the regulation of synaptic vesicle exocytosis (PubMed:24610330)

LOCALIZAÇÃO

Cytoplasm, cytosolGolgi apparatus, trans-Golgi networkCytoplasm, cytoskeletonGolgi apparatusNucleus

MECANISMO DE DOENÇA

Hypotonia-cystinuria syndrome

Characterized generalized hypotonia at birth, nephrolithiasis, growth hormone deficiency, minor facial dysmorphism, failure to thrive, followed by hyperphagia and rapid weight gain in late childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
148.0 TPM
Brain Frontal Cortex BA9
133.0 TPM
Cerebelo
92.0 TPM
Brain Nucleus accumbens basal ganglia
82.8 TPM
Hipotálamo
79.1 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (5)
myasthenic syndrome, congenital, 222p21 microdeletion syndrome without cystinuriahypotonia-cystinuria syndrome2p21 microdeletion syndrome
HGNC:30228UniProt:Q4J6C6
SCN1ASodium channel protein type 1 subunit alphaCandidate gene tested inAltamente restrito
FUNÇÃO

Pore-forming subunit of Nav1.1, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 2

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
15.1 TPM
Cérebro - Hemisfério cerebelar
10.7 TPM
Cerebelo
9.3 TPM
Córtex cerebral
8.9 TPM
Hipotálamo
6.3 TPM
OUTRAS DOENÇAS (13)
developmental and epileptic encephalopathy, 6Ageneralized epilepsy with febrile seizures plus, type 2developmental and epileptic encephalopathy 6Bfamilial hemiplegic migraine
HGNC:10585UniProt:P35498
KCNB1Potassium voltage-gated channel subfamily B member 1Candidate gene tested inAltamente restrito
FUNÇÃO

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain, but also in the pancreas and cardiovascular system. Contributes to the regulation of the action potential (AP) repolarization, duration and frequency of repetitive AP firing in neurons, muscle cells and endocrine cells and plays a role in homeostatic attenuation of electrical excitability throughout the brain (PubMed:23161216). Plays also a role in the regulation of exo

LOCALIZAÇÃO

Cell membranePerikaryonCell projection, axonCell projection, dendriteMembranePostsynaptic cell membraneSynapseSynapse, synaptosomeLateral cell membraneCell membrane, sarcolemma

VIAS BIOLÓGICAS (2)
Glucagon-like Peptide-1 (GLP1) regulates insulin secretionVoltage gated Potassium channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 26

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE26 patients manifest multiple types of seizures, delayed psychomotor development, poor or absent speech, hypotonia, hypsarrhythmia.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
21.0 TPM
Córtex cerebral
16.8 TPM
Esôfago - Muscular
13.9 TPM
Esôfago - Junção
10.7 TPM
Brain Anterior cingulate cortex BA24
8.4 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 26undetermined early-onset epileptic encephalopathy
HGNC:6231UniProt:Q14721
CELF2CUGBP Elav-like family member 2Candidate gene tested inAltamente restrito
FUNÇÃO

RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of TNNT2 in embryonic, but not adult, skeletal muscle. Activates TNNT2 exon 5 inclusion by antagonizing the repressive effect of PTB. Acts both as an activ

LOCALIZAÇÃO

NucleusCytoplasm

MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 97

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE97 is an autosomal dominant form.

OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 97undetermined early-onset epileptic encephalopathy
HGNC:2550UniProt:O95319
CACNA2D1Voltage-dependent calcium channel subunit alpha-2/delta-1Candidate gene tested inAltamente restrito
FUNÇÃO

The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity)

LOCALIZAÇÃO

MembraneCell membrane

VIAS BIOLÓGICAS (1)
Presynaptic depolarization and calcium channel opening
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 110

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE110 is an autosomal recessive form characterized by profound global developmental delay and hypotonia apparent in infancy followed by onset of seizures in the first months or years of life.

OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy 110undetermined early-onset epileptic encephalopathyBrugada syndromeshort QT syndrome
HGNC:1399UniProt:P54289
PACS2Phosphofurin acidic cluster sorting protein 2Candidate gene tested inAltamente restrito
FUNÇÃO

Multifunctional sorting protein that controls the endoplasmic reticulum (ER)-mitochondria communication, including the apposition of mitochondria with the ER and ER homeostasis. In addition, in response to apoptotic inducer, translocates BIB to mitochondria, which initiates a sequence of events including the formation of mitochondrial truncated BID, the release of cytochrome c, the activation of caspase-3 thereby causing cell death. May also be involved in ion channel trafficking, directing acid

LOCALIZAÇÃO

Endoplasmic reticulumMitochondrion

MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 66

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE66 is an autosomal dominant form characterized by onset of seizures in first days or weeks of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
188.4 TPM
Cerebelo
113.5 TPM
Cérebro - Hemisfério cerebelar
101.9 TPM
Nervo tibial
89.5 TPM
Substância negra
70.5 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 66undetermined early-onset epileptic encephalopathy
HGNC:23794UniProt:Q86VP3
NECAP1Adaptin ear-binding coat-associated protein 1Candidate gene tested inRestrito
FUNÇÃO

Involved in endocytosis

LOCALIZAÇÃO

Cytoplasmic vesicle, clathrin-coated vesicle membraneCell membrane

VIAS BIOLÓGICAS (2)
Clathrin-mediated endocytosisCargo recognition for clathrin-mediated endocytosis
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 21

A severe disease characterized by intractable seizures, profound global developmental delay, and persistent severe axial hypotonia as well as appendicular hypertonia.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
130.3 TPM
Cerebelo
92.7 TPM
Brain Frontal Cortex BA9
78.6 TPM
Pituitária
56.8 TPM
Hipotálamo
53.1 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 21undetermined early-onset epileptic encephalopathy
HGNC:24539UniProt:Q8NC96
FBXO28F-box only protein 28Candidate gene tested inAltamente restrito
FUNÇÃO

Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex, promoting ubiquitination and proteasomal degradation of specific target proteins including TOP2A, RAB27A or itself (PubMed:27754753, PubMed:31678254). Regulates topoisomerase IIalpha/TOP2A decatenation activity and plays an important role in maintaining genomic stability (PubMed:27754753). Plays a role in lipid metabolism and inflammation through the ubiquitinated degradation of RAB27A (By simi

LOCALIZAÇÃO

Chromosome, centromere, kinetochoreNucleusChromosome

MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 100

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE100 is an autosomal dominant, severe form characterized by global developmental delay and onset of variable types of seizures in the first months or years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
30.6 TPM
Skin Not Sun Exposed Suprapubic
26.9 TPM
Fibroblastos
21.6 TPM
Cérebro - Hemisfério cerebelar
20.7 TPM
Artéria tibial
20.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 100undetermined early-onset epileptic encephalopathy
HGNC:29046UniProt:Q9NVF7
DNM1Dynamin-1Candidate gene tested inAltamente restrito
FUNÇÃO

Catalyzes the hydrolysis of GTP and utilizes this energy to mediate vesicle scission and participates in many forms of endocytosis, such as clathrin-mediated endocytosis or synaptic vesicle endocytosis as well as rapid endocytosis (RE) (PubMed:15703209, PubMed:20428113, PubMed:29668686, PubMed:8101525, PubMed:8910402, PubMed:9362482). Associates to the membrane, through lipid binding, and self-assembles into rings and stacks of interconnected rings through oligomerization to form a helical polym

LOCALIZAÇÃO

Cell membraneMembrane, clathrin-coated pitCytoplasmic vesiclePresynapseCytoplasmic vesicle, secretory vesicle, chromaffin granule

VIAS BIOLÓGICAS (7)
Gap junction degradationFormation of annular gap junctionsRetrograde neurotrophin signallingRecycling pathway of L1MHC class II antigen presentation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 31A

An autosomal dominant epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
373.8 TPM
Cérebro - Hemisfério cerebelar
367.4 TPM
Brain Frontal Cortex BA9
260.3 TPM
Córtex cerebral
254.5 TPM
Brain Anterior cingulate cortex BA24
127.4 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 31Adevelopmental and epileptic encephalopathy, 31Bundetermined early-onset epileptic encephalopathyLennox-Gastaut syndrome
HGNC:2972UniProt:Q05193
IMPG1Interphotoreceptor matrix proteoglycan 1Candidate gene tested inTolerante
FUNÇÃO

Chondroitin sulfate-, heparin- and hyaluronan-binding protein (By similarity). May serve to form a basic macromolecular scaffold comprising the insoluble interphotoreceptor matrix (PubMed:9813076)

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentSecreted, extracellular space, extracellular matrix, interphotoreceptor matrixPhotoreceptor inner segment

MECANISMO DE DOENÇA

Macular dystrophy, vitelliform, 4

A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD4 features include late-onset moderate visual impairment, small satellite drusen-like lesions in the foveal area, and preservation of retinal pigment epithelium reflectivity.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Nucleus accumbens basal ganglia
3.2 TPM
Brain Caudate basal ganglia
1.5 TPM
Cerebelo
1.2 TPM
Brain Putamen basal ganglia
1.0 TPM
Brain Frontal Cortex BA9
0.8 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (4)
vitelliform macular dystrophy 4benign concentric annular macular dystrophyretinitis pigmentosaadult-onset foveomacular vitelliform dystrophy
HGNC:6055UniProt:Q17R60
BEST1Bestrophin-1Candidate gene tested inTolerante
FUNÇÃO

Ligand-gated anion channel that allows the movement of anions across cell membranes when activated by calcium (Ca2+) (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Allows the movement of chloride and hydrogencarbonate (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Found in a partiall

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Macular dystrophy, vitelliform, 2

An autosomal dominant form of macular degeneration that usually begins in childhood or adolescence. VMD2 is characterized by typical 'egg-yolk' macular lesions due to abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. Progression of the disease leads to destruction of the retinal pigment epithelium and vision loss.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
vitelliform macular dystrophy 2retinitis pigmentosa 50autosomal dominant vitreoretinochoroidopathyautosomal recessive bestrophinopathy
HGNC:12703UniProt:O76090
BBS2BBSome complex member BBS2Candidate gene tested inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 2

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (4)
Bardet-Biedl syndrome 2retinitis pigmentosa 74retinitis pigmentosaBardet-Biedl syndrome
HGNC:967UniProt:Q9BXC9
IFT172Intraflagellar transport protein 172 homologCandidate gene tested inTolerante
FUNÇÃO

Required for the maintenance and formation of cilia. Plays an indirect role in hedgehog (Hh) signaling, cilia being required for all activity of the hedgehog pathway (By similarity)

LOCALIZAÇÃO

Cell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 10 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
57.3 TPM
Pituitária
51.2 TPM
Ovário
41.6 TPM
Tireoide
30.7 TPM
Cerebelo
30.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 71Bardet-Biedl syndrome 20short-rib thoracic dysplasia 10 with or without polydactylyshort-rib thoracic dysplasia 9 with or without polydactyly
HGNC:30391UniProt:Q9UG01
PDE6GRetinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaCandidate gene tested inTolerante
FUNÇÃO

Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones

LOCALIZAÇÃO

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 57

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
8.5 TPM
Linfócitos
8.0 TPM
Sangue
2.8 TPM
Testículo
2.5 TPM
Rim - Medula
2.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 57retinitis pigmentosa
HGNC:8789UniProt:P18545
CRXCone-rod homeobox proteinCandidate gene tested inModerado
FUNÇÃO

Transcription factor that binds and transactivates the sequence 5'-TAATC[CA]-3' which is found upstream of several photoreceptor-specific genes, including the opsin genes. Acts synergistically with other transcription factors, such as NRL, RORB and RAX, to regulate photoreceptor cell-specific gene transcription. Essential for the maintenance of mammalian photoreceptors

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Leber congenital amaurosis 7

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Fígado
0.1 TPM
Ovário
0.0 TPM
Cerebelo
0.0 TPM
Cérebro - Hemisfério cerebelar
0.0 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 7cone-rod dystrophy 2retinitis pigmentosacone-rod dystrophy
HGNC:2383UniProt:O43186
AHRAryl hydrocarbon receptorCandidate gene tested inRestrito
FUNÇÃO

Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer (PubMed:23275542, PubMed:30373764, PubMed:32818467, PubMed:7961644). Upon ligand binding, translocates into the nucleus, where it heterodimerizes with ARNT and induces transcription by binding to xenobiotic response elements (XRE) (PubMed:23275542, PubMed:30

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Aryl hydrocarbon receptor signalling
MECANISMO DE DOENÇA

Retinitis pigmentosa 85

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP85 is an autosomal recessive form manifesting as early-onset progressive difficulty to adapt in dim light and gradually decreasing visual acuity in both eyes.

OUTRAS DOENÇAS (3)
foveal hypoplasia 3retinitis pigmentosa 85retinitis pigmentosa
HGNC:348UniProt:P35869
SLC6A17Sodium-dependent neutral amino acid transporter SLC6A17Candidate gene tested inAltamente restrito
FUNÇÃO

Synaptic vesicle transporter with apparent selectivity for neutral amino acids. The transport is sodium-coupled but chloride-independent, likely driven by the proton electrochemical gradient generated by vacuolar H(+)-ATPase in an overall electrogenic mechanism. May contribute to the synaptic uptake of neurotransmitter precursors in a process coupled in part to vesicle exocytosis

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membranePostsynapsePresynapse

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 48

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT48 patients show moderate to severe intellectual disability and additional features including progressive tremor, speech impairment, and sometimes behavioral problems.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
88.5 TPM
Cerebelo
84.1 TPM
Córtex cerebral
80.5 TPM
Cérebro - Hemisfério cerebelar
73.4 TPM
Pituitária
53.6 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome
HGNC:31399UniProt:Q9H1V8
SLC6A20Sodium- and chloride-dependent transporter XTRP3Candidate gene tested inTolerante
FUNÇÃO

Mediates the Na(+)- and Cl(-)-dependent uptake of imino acids such as L-proline, N-methyl-L-proline and pipecolate as well as N-methylated amino acids (PubMed:15632147, PubMed:19033659, PubMed:33428810). Also transports glycine, regulates proline and glycine homeostasis in the brain playing a role in the modulation of NMDAR currents (PubMed:33428810)

LOCALIZAÇÃO

Apical cell membrane

VIAS BIOLÓGICAS (2)
Amino acid transport across the plasma membraneSLC-mediated transport of neurotransmitters
MECANISMO DE DOENÇA

Hyperglycinuria

A condition characterized by excess of glycine in the urine. In some cases it is associated with renal colic and renal oxalate stones.

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
12.3 TPM
Intestino delgado
9.7 TPM
Cervix Endocervix
2.3 TPM
Pâncreas
1.9 TPM
Pituitária
1.4 TPM
OUTRAS DOENÇAS (1)
iminoglycinuria
HGNC:30927UniProt:Q9NP91
YWHAG14-3-3 protein gammaCandidate gene tested inAltamente restrito
FUNÇÃO

Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:15696159, PubMed:16511572, PubMed:36732624). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:15696159, PubMed:16511572, PubMed:36732624). Binding generally results in the modulation of the activity of the binding partner (PubMed:16511572). Promotes inactivation of WDR24 component of the GATOR2 complex by bindi

LOCALIZAÇÃO

Cytoplasm, cytosolMitochondrion matrix

VIAS BIOLÓGICAS (10)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 56

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE56 is an autosomal dominant condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
554.5 TPM
Cérebro - Hemisfério cerebelar
317.8 TPM
Brain Anterior cingulate cortex BA24
299.5 TPM
Córtex cerebral
261.1 TPM
Hipotálamo
238.6 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 56undetermined early-onset epileptic encephalopathy
HGNC:12852UniProt:P61981
SZT2KICSTOR complex protein SZT2Candidate gene tested inRestrito
FUNÇÃO

As part of the KICSTOR complex functions in the amino acid-sensing branch of the TORC1 signaling pathway. Recruits, in an amino acid-independent manner, the GATOR1 complex to the lysosomal membranes and allows its interaction with GATOR2 and the RAG GTPases. Functions upstream of the RAG GTPases and is required to negatively regulate mTORC1 signaling in absence of amino acids. In absence of the KICSTOR complex mTORC1 is constitutively localized to the lysosome and activated. The KICSTOR complex

LOCALIZAÇÃO

Lysosome membranePeroxisome

VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 18

A severe autosomal recessive neurologic disorder characterized by lack of psychomotor development apparent from birth, dysmorphic facial features, early onset of refractory seizures, and thick corpus callosum and persistent cavum septum pellucidum on brain imaging.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
25.3 TPM
Testículo
24.8 TPM
Ovário
22.8 TPM
Pituitária
22.4 TPM
Cerebelo
22.3 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 18undetermined early-onset epileptic encephalopathy
HGNC:29040UniProt:Q5T011
KCNC2Voltage-gated potassium channel KCNC2Candidate gene tested inTolerante
FUNÇÃO

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain. Contributes to the regulation of the fast action potential repolarization and in sustained high-frequency firing in neurons of the central nervous system. Homotetramer channels mediate delayed-rectifier voltage-dependent potassium currents that activate rapidly at high-threshold voltages and inactivate slowly. Forms tetrameric channels through which potassium ions pass

LOCALIZAÇÃO

Cell membraneMembranePerikaryonCell projection, axonCell projection, dendritePostsynaptic cell membranePresynaptic cell membraneSynapse, synaptosomeSynapseApical cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (2)
Glucagon-like Peptide-1 (GLP1) regulates insulin secretionVoltage gated Potassium channels
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
37.0 TPM
Brain Anterior cingulate cortex BA24
22.2 TPM
Córtex cerebral
22.1 TPM
Pituitária
9.7 TPM
Hipotálamo
9.1 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 103undetermined early-onset epileptic encephalopathy
HGNC:6234UniProt:Q96PR1
ATP6V1AV-type proton ATPase catalytic subunit ACandidate gene tested inAltamente restrito
FUNÇÃO

Catalytic subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:8463241). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091). In aerobic conditions, invol

LOCALIZAÇÃO

CytoplasmCytoplasm, cytosolCytoplasmic vesicle, secretory vesicleCytoplasmic vesicle, clathrin-coated vesicle membraneLysosome

VIAS BIOLÓGICAS (6)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transportROS and RNS production in phagocytesAmino acids regulate mTORC1
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2D

A form of cutis laxa, a disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, and a general connective tissue weakness. Most ARCL2D patients exhibit severe hypotonia as well as cardiovascular and neurologic involvement.

OUTRAS DOENÇAS (4)
autosomal recessive cutis laxa type 2Ddevelopmental and epileptic encephalopathy 93undetermined early-onset epileptic encephalopathyautosomal recessive cutis laxa type 2, classic type
HGNC:851UniProt:P38606
AP3B2AP-3 complex subunit beta-2Candidate gene tested inRestrito
FUNÇÃO

Subunit of non-clathrin- and clathrin-associated adaptor protein complex 3 (AP-3) that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules. AP-3 appears to be involved in the sorting of a subset of transmembrane proteins targeted to lysosomes and lysosome-related organelles. In concert w

LOCALIZAÇÃO

Cytoplasmic vesicle, clathrin-coated vesicle membraneGolgi apparatus

MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 48

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE48 is an autosomal recessive form characterized by onset of seizures in the first year of life. Affected individuals manifest global developmental delay, intellectual disability, absent speech, and poor, if any, motor development.

OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 48undetermined early-onset epileptic encephalopathy
HGNC:567UniProt:Q13367
CNGA1Cyclic nucleotide-gated channel alpha-1Candidate gene tested inTolerante
FUNÇÃO

Pore-forming subunit of the rod cyclic nucleotide-gated channel. Mediates rod photoresponses at dim light converting transient changes in intracellular cGMP levels into electrical signals. In the dark, cGMP levels are high and keep the channel open enabling a steady inward current carried by Na(+) and Ca(2+) ions that leads to membrane depolarization and neurotransmitter release from synaptic terminals. Upon photon absorption cGMP levels decline leading to channel closure and membrane hyperpolar

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 49

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 49retinitis pigmentosa
HGNC:2148UniProt:P29973
MERTKTyrosine-protein kinase MerCandidate gene tested inTolerante
FUNÇÃO

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by l

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Cell surface interactions at the vascular wallDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Retinitis pigmentosa 38

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
52.4 TPM
Artéria tibial
46.6 TPM
Baço
37.9 TPM
Aorta
33.9 TPM
Testículo
31.7 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 38retinitis pigmentosa
HGNC:7027UniProt:Q12866
TTC8Tetratricopeptide repeat protein 8Candidate gene tested inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteCell projection, cilium

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Retinitis pigmentosa 51

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
40.7 TPM
Pituitária
30.5 TPM
Testículo
20.5 TPM
Glândula adrenal
19.6 TPM
Tireoide
18.3 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 51Bardet-Biedl syndrome 8retinitis pigmentosaBardet-Biedl syndrome
HGNC:20087UniProt:Q8TAM2
RP1Microtubule-associated protein RP/EB family member 2Candidate gene tested inTolerante
FUNÇÃO

Adapter protein that is involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. Therefore, ensures mitotic progression and genome stability (PubMed:27030108). Acts as a central regulator of microtubule reorganization in apico-basal epithelial differentiation (By similarity). Plays a role during oocyte meiosis by regulating microtubule dynamics (By similarity). Participates in neurite growth by interacting with plexin B3/PLXNB3 a

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

MECANISMO DE DOENÇA

Skin creases, congenital symmetric circumferential, 2

An autosomal dominant disease characterized by multiple, symmetric, circumferential rings of folded skin, affecting primarily the limbs. Affected individuals also exhibit intellectual disability, cleft palate, and dysmorphic features.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
0.9 TPM
Pulmão
0.8 TPM
Rim - Medula
0.3 TPM
Fallopian Tube
0.3 TPM
Estômago
0.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 1retinitis pigmentosa
HGNC:10263UniProt:Q15555
SLC3A1Amino acid transporter heavy chain SLC3A1Candidate gene tested inTolerante
FUNÇÃO

Acts as a chaperone that facilitates biogenesis and trafficking of functional transporter heteromers to the plasma membrane (By similarity) (PubMed:10588648, PubMed:11318953, PubMed:16609684, PubMed:16825196, PubMed:32494597, PubMed:32817565, PubMed:7686906, PubMed:8486766, PubMed:8663184, PubMed:8663357). Associates with SLC7A9 to form a functional transporter complex that mediates the electrogenic exchange between cationic amino acids and neutral amino acids, with a stoichiometry of 1:1. SLC7A

LOCALIZAÇÃO

Cell membraneApical cell membrane

VIAS BIOLÓGICAS (2)
Amino acid transport across the plasma membraneDefective SLC7A9 causes cystinuria (CSNU)
MECANISMO DE DOENÇA

Cystinuria

An autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
29.4 TPM
Rim - Medula
18.3 TPM
Intestino delgado
14.8 TPM
Pâncreas
13.7 TPM
Cólon transverso
2.2 TPM
OUTRAS DOENÇAS (5)
cystinuriacystinuria type Ahypotonia-cystinuria syndrome2p21 microdeletion syndrome
HGNC:11025UniProt:Q07837
PRCDPhotoreceptor disk component PRCDCandidate gene tested inTolerante
FUNÇÃO

Involved in vision

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentMembraneEndoplasmic reticulumGolgi apparatus

MECANISMO DE DOENÇA

Retinitis pigmentosa 36

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
21.0 TPM
Cérebro - Hemisfério cerebelar
20.5 TPM
Brain Spinal cord cervical c-1
8.0 TPM
Cervix Endocervix
6.6 TPM
Cervix Ectocervix
6.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 36retinitis pigmentosa
HGNC:32528UniProt:Q00LT1
MAKSerine/threonine-protein kinase MAKCandidate gene tested inTolerante
FUNÇÃO

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleMidbodyCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

VIAS BIOLÓGICAS (2)
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
MECANISMO DE DOENÇA

Retinitis pigmentosa 62

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
15.1 TPM
Sangue
2.7 TPM
Pituitária
1.8 TPM
Fallopian Tube
1.3 TPM
Baço
1.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 62retinitis pigmentosa
HGNC:6816UniProt:P20794
SNRNP200U5 small nuclear ribonucleoprotein 200 kDa helicaseCandidate gene tested inAltamente restrito
FUNÇÃO

Catalyzes the ATP-dependent unwinding of U4/U6 RNA duplices, an essential step in the assembly of a catalytically active spliceosome (PubMed:35241646). Plays a role in pre-mRNA splicing as a core component of precatalytic, catalytic and postcatalytic spliceosomal complexes (PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154, PubMed:30728453). As a component of the minor spliceosome, involved in the splicing of U12-type introns in

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
mRNA Splicing - Major PathwayDengue Virus-Host InteractionsmRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 33

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
153.3 TPM
Ovário
132.5 TPM
Útero
119.1 TPM
Cervix Endocervix
112.7 TPM
Cérebro - Hemisfério cerebelar
109.0 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 33retinitis pigmentosa
HGNC:30859UniProt:O75643
BBS1BBSome complex member BBS1Candidate gene tested inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
OUTRAS DOENÇAS (3)
Bardet-Biedl syndrome 1retinitis pigmentosaBardet-Biedl syndrome
HGNC:966UniProt:Q8NFJ9
GRM1Metabotropic glutamate receptor 1Candidate gene tested inAltamente restrito
FUNÇÃO

G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system. May participate in the central action of glutamate in the CNS, such as long-term potentiation in the hippocampus and long-term depression in the cerebellum (PubMed:24603153, PubMed:28886343, PubMed:7476890).

LOCALIZAÇÃO

Cell membranePostsynaptic cell membraneCell projection, dendrite

VIAS BIOLÓGICAS (3)
G alpha (q) signalling eventsClass C/3 (Metabotropic glutamate/pheromone receptors)Neurexins and neuroligins
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 13

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR13 is characterized by delayed psychomotor development beginning in infancy. Affected individuals show mild to profound intellectual disability with poor or absent speech as well as gait and stance ataxia and hyperreflexia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
38.4 TPM
Cerebelo
30.6 TPM
Brain Frontal Cortex BA9
5.7 TPM
Córtex cerebral
3.6 TPM
Brain Anterior cingulate cortex BA24
3.6 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia 44autosomal recessive spinocerebellar ataxia 13chondromyxoid fibroma
HGNC:4593UniProt:Q13255
SLC1A1Excitatory amino acid transporter 3Candidate gene tested inTolerante
FUNÇÃO

Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:21123949, PubMed:26690923, PubMed:33658209, PubMed:7521911, PubMed:7914198, PubMed:8857541). Can also transport L-cysteine (PubMed:21123949). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:26690923, PubMed:33658209, PubMed:75

LOCALIZAÇÃO

Cell membraneApical cell membraneSynapse, synaptosomeEarly endosome membraneLate endosome membraneRecycling endosome membrane

VIAS BIOLÓGICAS (2)
Glutamate Neurotransmitter Release CycleSLC-mediated transport of amino acids
MECANISMO DE DOENÇA

Dicarboxylic aminoaciduria

An autosomal recessive disorder characterized by abnormal excretion of urinary glutamate and aspartate, resulting from the incomplete reabsorption of anionic amino acids from the glomerular filtrate in the kidney. It can be associated with intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
33.4 TPM
Linfócitos
26.3 TPM
Fígado
23.9 TPM
Intestino delgado
22.8 TPM
Brain Frontal Cortex BA9
20.2 TPM
OUTRAS DOENÇAS (3)
dicarboxylic aminoaciduriahot water reflex epilepsyschizophrenia 18
HGNC:10939UniProt:P43005
RPGRX-linked retinitis pigmentosa GTPase regulatorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:20631154). GEF activity towards RAB8A may facilitate ciliary trafficking by modulating ciliary intracellular localization of RAB8A (PubMed:20631154). GEF activity towards RAB37 maintains autophagic homeostasis and retinal function (By similarity). Involved in photoreceptor integrity (By similarity). May control cilia formation by regulating ac

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, flagellum axonemeGolgi apparatusCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, cilium axoneme

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 3

An X-linked retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. In RP3, affected males have a severe phenotype, and carrier females show a wide spectrum of clinical features ranging from completely asymptomatic to severe retinitis pigmentosa. Heterozygous women can manifest a form of choroidoretinal degeneration which is distinguished from other types by the absence of visual defects in the presence of a brilliant, scintillating, golden-hued, patchy appearance most striking around the macula, called a tapetal-like retinal reflex.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
19.9 TPM
Nervo tibial
17.6 TPM
Tecido adiposo
15.5 TPM
Fallopian Tube
14.7 TPM
Pulmão
14.3 TPM
OUTRAS DOENÇAS (9)
macular degeneration, X-linked atrophicretinitis pigmentosa 3obsolete primary ciliary dyskinesia-retinitis pigmentosa syndromeX-linked cone-rod dystrophy 1
HGNC:10295UniProt:Q92834
FAM161AProtein FAM161ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in ciliogenesis

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole

MECANISMO DE DOENÇA

Retinitis pigmentosa 28

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
15.7 TPM
Ovário
10.0 TPM
Pituitária
8.4 TPM
Tireoide
7.0 TPM
Linfócitos
6.5 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 28retinitis pigmentosa
HGNC:25808UniProt:Q3B820
CERKLCeramide kinase-like proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Has no detectable ceramide-kinase activity. Overexpression of CERKL protects cells from apoptosis in oxidative stress conditions

LOCALIZAÇÃO

CytoplasmNucleus, nucleolusGolgi apparatus, trans-Golgi networkEndoplasmic reticulum

MECANISMO DE DOENÇA

Retinitis pigmentosa 26

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 26retinitis pigmentosa
HGNC:21699UniProt:Q49MI3
PRPF3U4/U6 small nuclear ribonucleoprotein Prp3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex)

LOCALIZAÇÃO

NucleusNucleus speckle

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 18

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
61.9 TPM
Tireoide
59.6 TPM
Nervo tibial
54.5 TPM
Cervix Endocervix
52.6 TPM
Cervix Ectocervix
50.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 18retinitis pigmentosa
HGNC:17348UniProt:O43395
TULP1Tubby-related protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal development of photoreceptor synapses. Required for normal photoreceptor function and for long-term survival of photoreceptor cells. Interacts with cytoskeleton proteins and may play a role in protein transport in photoreceptor cells (By similarity). Binds lipids, especially phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 3,4

LOCALIZAÇÃO

CytoplasmCell membraneSecretedSynapse

MECANISMO DE DOENÇA

Retinitis pigmentosa 14

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Próstata
1.5 TPM
Útero
1.4 TPM
Fallopian Tube
1.2 TPM
Cervix Endocervix
1.1 TPM
Skin Sun Exposed Lower leg
1.0 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 15retinitis pigmentosa 14Leber congenital amaurosisretinitis pigmentosa
HGNC:12423UniProt:O00294
SLC6A19Sodium-dependent neutral amino acid transporter B(0)AT1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells (PubMed:15286787, PubMed:15286788, PubMed:18424768, PubMed:18484095, PubMed:19185582, PubMed:26240152). This uptake is sodium-dependent and chloride-independent (PubMed:15286787, PubMed:15286788, PubMed:19185582). Requires CLTRN in kidney or ACE2 in intestine for cell surface expression and amino acid transporter activity (PubMed:18424768, PubMed:19185582)

LOCALIZAÇÃO

Cell membraneApical cell membrane

VIAS BIOLÓGICAS (2)
SLC-mediated transport of neurotransmittersAmino acid transport across the plasma membrane
MECANISMO DE DOENÇA

Hartnup disorder

Autosomal recessive abnormality of renal and gastrointestinal neutral amino acid transport noted for its clinical variability. First described in 1956, HND is characterized by increases in the urinary and intestinal excretion of neutral amino acids. Individuals with typical Hartnup aminoaciduria may be asymptomatic, some develop a photosensitive pellagra-like rash, attacks of cerebellar ataxia and other neurological or psychiatric features. Although the definition of HND was originally based on clinical and biochemical abnormalities, its marked clinical heterogeneity has led to it being known as a disorder with a consistent pathognomonic neutral hyperaminoaciduria.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
70.7 TPM
Rim - Córtex
20.2 TPM
Rim - Medula
5.5 TPM
Cólon transverso
0.6 TPM
Fígado
0.5 TPM
OUTRAS DOENÇAS (2)
Hartnup diseaseiminoglycinuria
HGNC:27960UniProt:Q695T7
CACNA1AVoltage-dependent P/Q-type calcium channel subunit alpha-1ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1A gives rise to P and/or Q-type calcium currents. P/Q-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by the spider omega-agatoxin-IVA

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Presynaptic depolarization and calcium channel openingRegulation of insulin secretion
MECANISMO DE DOENÇA

Spinocerebellar ataxia 6

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA), mainly caused by expansion of a CAG repeat in the coding region of CACNA1A. There seems to be a correlation between the repeat number and earlier onset of the disorder.

OUTRAS DOENÇAS (9)
migraine, familial hemiplegic, 1episodic ataxia type 2developmental and epileptic encephalopathy, 42spinocerebellar ataxia type 6
HGNC:1388UniProt:O00555
SLC13A5Na(+)/citrate cotransporterDisease-causing germline mutation(s) inTolerante
FUNÇÃO

High-affinity sodium/citrate cotransporter that mediates the entry of citrate into cells, which is a critical participant of biochemical pathways (PubMed:12445824, PubMed:12826022, PubMed:26324167, PubMed:26384929, PubMed:30054523, PubMed:33597751, PubMed:39622972). May function in various metabolic processes in which citrate has a critical role such as energy production (Krebs cycle), fatty acid synthesis, cholesterol synthesis, glycolysis, and gluconeogenesis (PubMed:12826022). Transports citr

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
SLC-mediated transport of organic anions
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta

An autosomal recessive disease characterized by subclinical seizures appearing in the first days of life, evolving to severe epileptic disease. Affected individuals have profound or severe delayed development with lack of speech, and most patients do not acquire the ability to sit. Additional variable features include axial hypotonia, peripheral hypertonia, and abnormal involuntary movements such as dystonia and choreoathetosis. Dental abnormalities, including delayed eruption, hypodontia, tooth hypoplasia, yellow discoloration, thin enamel, and enamel chipping are observed in most patients.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
261.8 TPM
Brain Nucleus accumbens basal ganglia
7.1 TPM
Córtex cerebral
7.0 TPM
Brain Anterior cingulate cortex BA24
6.0 TPM
Brain Frontal Cortex BA9
5.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
developmental and epileptic encephalopathy, 25undetermined early-onset epileptic encephalopathyamelocerebrohypohidrotic syndrome
HGNC:23089UniProt:Q86YT5
HCN1Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Hyperpolarization-activated ion channel that are permeable to sodium and potassium ions (PubMed:15351778, PubMed:28086084). Displays lower selectivity for K(+) over Na(+) ions (PubMed:28086084). Contributes to the native pacemaker currents in heart (If) and in the generation of the I(h) current which controls neuron excitability (PubMed:29936235, PubMed:30351409). Participates in cerebellar mechanisms of motor learning (By similarity). May mediate responses to sour stimuli (By similarity)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
HCN channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 24

A disease characterized by early-onset seizures, intellectual disability of varying degrees, and behavioral disturbances or autistic features in most individuals.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
9.1 TPM
Cérebro - Hemisfério cerebelar
5.7 TPM
Nervo tibial
5.3 TPM
Córtex cerebral
5.2 TPM
Cerebelo
4.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
generalized epilepsy with febrile seizures plus, type 10developmental and epileptic encephalopathy, 24undetermined early-onset epileptic encephalopathygeneralized epilepsy with febrile seizures plus
HGNC:4845UniProt:O60741
OCRLInositol polyphosphate 5-phosphatase OCRLDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the hydrolysis of the 5-position phosphate of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and phosphatidylinositol-3,4,5-bisphosphate (PtdIns(3,4,5)P3), with the greatest catalytic activity towards PtdIns(4,5)P2 (PubMed:10764818, PubMed:15474001, PubMed:7761412, PubMed:9430698). Able also to hydrolyze the 5-phosphate of inositol 1,4,5-trisphosphate and of inositol 1,3,4,5-tetrakisphosphate (PubMed:25869668, PubMed:7761412). Regulates traffic in the endosomal pathway by regula

LOCALIZAÇÃO

Cytoplasmic vesicle, phagosome membraneEarly endosome membraneMembrane, clathrin-coated pitCell projection, cilium, photoreceptor outer segmentCell projection, ciliumCytoplasmic vesicleEndosomeGolgi apparatus, trans-Golgi networkLysosome

VIAS BIOLÓGICAS (1)
Synthesis of IP3 and IP4 in the cytosol
MECANISMO DE DOENÇA

Lowe oculocerebrorenal syndrome

X-linked multisystem disorder affecting eyes, nervous system, and kidney. It is characterized by hydrophthalmia, cataract, intellectual disability, vitamin D-resistant rickets, aminoaciduria, and reduced ammonia production by the kidney. Ocular abnormalities include cataract, glaucoma, microphthalmos, and decreased visual acuity. Developmental delay, hypotonia, behavior abnormalities, and areflexia are also present. Renal tubular involvement is characterized by impaired reabsorption of bicarbonate, amino acids, and phosphate. Musculoskeletal abnormalities such as joint hypermobility, dislocated hips, and fractures may develop as consequences of renal tubular acidosis and hypophosphatemia. Cataract is the only significant manifestation in carriers and is detected by slit-lamp examination.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Junção
60.2 TPM
Esôfago - Muscular
56.6 TPM
Testículo
55.8 TPM
Ovário
55.0 TPM
Pituitária
48.3 TPM
OUTRAS DOENÇAS (2)
oculocerebrorenal syndromeDent disease type 2
HGNC:8108UniProt:Q01968
SLC38A8Solute carrier family 38 member 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Electrogenic sodium-dependent amino acid transporter with a preference for L-glutamine, L-alanine, L-histidine, L-aspartate and L-arginine. May facilitate glutamine uptake in both excitatory and inhibitory neurons. The transport mechanism and stoichiometry remain to be elucidated

LOCALIZAÇÃO

MembraneCytoplasm, cell cortexCell projection, axon

MECANISMO DE DOENÇA

Foveal hypoplasia 2

An isolated form of foveal hypoplasia, a developmental defect of the eye defined as the lack of foveal depression with continuity of all neurosensory retinal layers in the presumed foveal area. Clinical features include absence of foveal pit on optical coherence tomography, absence of foveal hyperpigmentation, absence of foveal avascularity, absence of foveal and macular reflexes, decreased visual acuity, and nystagmus. Optic nerve misrouting and anterior segment dysgenesis are observed in some FVH2 patients.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cérebro - Amígdala
1.7 TPM
Pituitária
1.4 TPM
Brain Frontal Cortex BA9
1.2 TPM
Córtex cerebral
1.1 TPM
Testículo
0.8 TPM
OUTRAS DOENÇAS (1)
foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome
HGNC:32434UniProt:A6NNN8
KCNA2Potassium voltage-gated channel subfamily A member 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the cardiovascular system. Prevents aberrant action potential firing and regulates neuronal output. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage differen

LOCALIZAÇÃO

Cell membraneMembraneCell projection, axonSynapseEndoplasmic reticulum membraneCell projection, lamellipodium membraneSynapse, synaptosomePresynaptic cell membraneCell projection, dendriteCell junction, paranodal septate junction

VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 32

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE32 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
35.9 TPM
Cérebro - Hemisfério cerebelar
29.5 TPM
Córtex cerebral
19.8 TPM
Brain Frontal Cortex BA9
18.9 TPM
Nervo tibial
12.2 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 32undetermined early-onset epileptic encephalopathy
HGNC:6220UniProt:P16389
SLC7A9b(0,+)-type amino acid transporter 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Associates with SLC3A1 to form a functional transporter complex that mediates the electrogenic exchange between cationic amino acids and neutral amino acids, with a stoichiometry of 1:1 (PubMed:16825196, PubMed:32494597, PubMed:32817565, PubMed:8663357). Has system b(0,+)-like activity with high affinity for extracellular cationic amino acids and L-cystine and lower affinity for intracellular neutral amino acids (PubMed:16825196, PubMed:32494597, PubMed:8663357). Substrate exchange is driven by

LOCALIZAÇÃO

Apical cell membraneCell membrane

VIAS BIOLÓGICAS (3)
Basigin interactionsAmino acid transport across the plasma membraneDefective SLC3A1 causes cystinuria (CSNU)
MECANISMO DE DOENÇA

Cystinuria

An autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
44.8 TPM
Rim - Córtex
11.1 TPM
Fígado
7.1 TPM
Rim - Medula
3.3 TPM
Cerebelo
2.1 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
cystinuriacystinuria type B
HGNC:11067UniProt:P82251
CTNSCystinosinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Cystine/H(+) symporter that mediates export of cystine, the oxidized dimer of cysteine, from lysosomes (PubMed:11689434, PubMed:15128704, PubMed:18337546, PubMed:22232659, PubMed:29467429, PubMed:33208952, PubMed:36113465). Plays an important role in melanin synthesis by catalyzing cystine export from melanosomes, possibly by inhibiting pheomelanin synthesis (PubMed:22649030). In addition to cystine export, also acts as a positive regulator of mTORC1 signaling in kidney proximal tubular cells, v

LOCALIZAÇÃO

Lysosome membraneMelanosome membraneCell membrane

VIAS BIOLÓGICAS (2)
Miscellaneous transport and binding eventsSLC-mediated transport of oligopeptides
MECANISMO DE DOENÇA

Cystinosis, nephropathic type

A form of cystinosis, a lysosomal storage disease due to defective transport of cystine across the lysosomal membrane. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. The classical nephropathic form has onset in the first year of life and is characterized by a polyuro-polydipsic syndrome, marked height-weight growth delay, generalized impaired proximal tubular reabsorptive capacity, with severe fluid-electrolyte balance alterations, renal failure, ocular symptoms and other systemic complications.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
48.4 TPM
Nervo tibial
37.2 TPM
Cervix Endocervix
29.4 TPM
Cervix Ectocervix
28.7 TPM
Ovário
24.3 TPM
OUTRAS DOENÇAS (4)
juvenile nephropathic cystinosisnephropathic cystinosisocular cystinosisnephropathic infantile cystinosis
HGNC:2518UniProt:O60931
GABRB1Gamma-aminobutyric acid receptor subunit beta-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Beta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:10449790, PubMed:16412217, PubMed:26950270). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain one or two GABA active binding sites located at the alpha and beta subunit interfaces, depending on subunit composition (By similarity). When activated b

LOCALIZAÇÃO

Postsynaptic cell membraneCell membrane

VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 45

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Nucleus accumbens basal ganglia
2.9 TPM
Brain Caudate basal ganglia
2.8 TPM
Pituitária
2.3 TPM
Córtex cerebral
2.3 TPM
Brain Frontal Cortex BA9
2.3 TPM
OUTRAS DOENÇAS (1)
developmental and epileptic encephalopathy, 45
HGNC:HGNC:4081UniProt:P18505
EEF1A2Elongation factor 1-alpha 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis. Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome (By similarity). The growing protein chain is subsequently transferred from the P-site peptidyl tRNA to the A-site aa-tRNA, extending it by one amino acid

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Eukaryotic Translation Elongation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 33

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
2328.3 TPM
Cérebro - Hemisfério cerebelar
972.3 TPM
Cerebelo
934.2 TPM
Coração - Ventrículo esquerdo
786.7 TPM
Brain Frontal Cortex BA9
785.6 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 33intellectual disability, autosomal dominant 38undetermined early-onset epileptic encephalopathyautosomal dominant non-syndromic intellectual disability
HGNC:3192UniProt:Q05639
PDE6BRod cGMP-specific 3',5'-cyclic phosphodiesterase subunit betaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP (PubMed:20940301). Necessary for the formation of a functional phosphodiesterase holoenzyme (By similarity). Involved in retinal circadian rhythm photoentrainment via modulation of UVA and orange light-induced phase-shift of the retina clock (By similarity). May participate in processes of transmission and amplification of the visual signal (PubMed:8394174)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Ca2+ pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 40

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
22.1 TPM
Hipocampo
14.7 TPM
Brain Caudate basal ganglia
14.3 TPM
Brain Nucleus accumbens basal ganglia
13.9 TPM
Substância negra
13.4 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 40congenital stationary night blindness autosomal dominant 2retinitis pigmentosa
HGNC:8786UniProt:P35913
IDH3AIsocitrate dehydrogenase [NAD] subunit alpha, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic subunit of the enzyme which catalyzes the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (2)
Citric acid cycle (TCA cycle)Mitochondrial protein degradation
MECANISMO DE DOENÇA

Retinitis pigmentosa 90

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP90 is an autosomal recessive form.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
41.9 TPM
Coração - Átrio
30.6 TPM
Artéria tibial
26.4 TPM
Cérebro - Hemisfério cerebelar
25.3 TPM
Músculo esquelético
25.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 90retinitis pigmentosa
HGNC:5384UniProt:P50213
DHX38Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Probable ATP-binding RNA helicase (Probable). Involved in pre-mRNA splicing as component of the spliceosome (PubMed:29301961, PubMed:9524131)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Transport of Mature mRNA derived from an Intron-Containing TranscriptmRNA 3'-end processingRNA Polymerase II Transcription TerminationmRNA Splicing - Major PathwayDengue Virus-Host Interactions
MECANISMO DE DOENÇA

Retinitis pigmentosa 84

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP84 is an autosomal recessive, early onset form characterized by night blindness by age 4 and complete blindness by age 8. Funduscopy shows severely attenuated retinal vessels, severe macular atrophy, and prominent and deep macular colobomas lacking neuroretinal tissue.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
73.7 TPM
Ovário
73.6 TPM
Útero
70.1 TPM
Linfócitos
62.6 TPM
Cervix Ectocervix
62.0 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 84retinitis pigmentosa
HGNC:17211UniProt:Q92620
HGSNATHeparan-alpha-glucosaminide N-acetyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Lysosomal acetyltransferase that acetylates the non-reducing terminal alpha-glucosamine residue of intralysosomal heparin or heparan sulfate, converting it into a substrate for luminal alpha-N-acetyl glucosaminidase

LOCALIZAÇÃO

Lysosome membrane

VIAS BIOLÓGICAS (1)
HS-GAG degradation
MECANISMO DE DOENÇA

Mucopolysaccharidosis 3C

A form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
80.4 TPM
Cervix Ectocervix
76.1 TPM
Ovário
71.9 TPM
Nervo tibial
67.3 TPM
Útero
66.7 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (3)
mucopolysaccharidosis type 3Cretinitis pigmentosa 73retinitis pigmentosa
HGNC:26527UniProt:Q68CP4
PRPF4U4/U6 small nuclear ribonucleoprotein Prp4Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex)

LOCALIZAÇÃO

NucleusNucleus speckle

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 70

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
46.9 TPM
Fibroblastos
44.2 TPM
Ovário
29.4 TPM
Testículo
26.3 TPM
Cervix Endocervix
25.1 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 70retinitis pigmentosa
HGNC:17349UniProt:O43172
CDHR1Cadherin-related family member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Potential calcium-dependent cell-adhesion protein. May be required for the structural integrity of the outer segment (OS) of photoreceptor cells (By similarity)

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Cone-rod dystrophy 15

An autosomal recessive retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (3)
cone-rod dystrophy 15cone-rod dystrophyretinitis pigmentosa
HGNC:14550UniProt:Q96JP9
CLRN1Clarin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May have a role in the excitatory ribbon synapse junctions between hair cells and cochlear ganglion cells and presumably also in analogous synapses within the retina

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Usher syndrome 3A

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH3 is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life.

OUTRAS DOENÇAS (4)
retinitis pigmentosa 61Usher syndrome type 3AUsher syndrome type 3retinitis pigmentosa
HGNC:12605UniProt:P58418
DHDDSDehydrodolichyl diphosphate synthase complex subunit DHDDSDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

With NUS1, forms the dehydrodolichyl diphosphate synthase (DDS) complex, an essential component of the dolichol monophosphate (Dol-P) biosynthetic machinery (PubMed:25066056, PubMed:28842490, PubMed:32817466, PubMed:33077723). Both subunits contribute to enzymatic activity, i.e. condensation of multiple copies of isopentenyl pyrophosphate (IPP) to farnesyl pyrophosphate (FPP) to produce dehydrodolichyl diphosphate (Dedol-PP), a precursor of dolichol phosphate which is utilized as a sugar carrier

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of dolichyl-phosphate
MECANISMO DE DOENÇA

Retinitis pigmentosa 59

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
95.1 TPM
Cérebro - Hemisfério cerebelar
91.4 TPM
Tecido adiposo
33.3 TPM
Fibroblastos
27.0 TPM
Skin Sun Exposed Lower leg
25.7 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 59developmental delay and seizures with or without movement abnormalitiesretinitis pigmentosaundetermined early-onset epileptic encephalopathy
HGNC:20603UniProt:Q86SQ9
SLC7A7Y+L amino acid transporter 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Heterodimer with SLC3A2, that functions as an antiporter which operates as an efflux route by exporting cationic amino acids from inside the cells in exchange with neutral amino acids plus sodium ions and may participate in nitric oxide synthesis via the transport of L-arginine (PubMed:10080182, PubMed:10655553, PubMed:14603368, PubMed:15756301, PubMed:15776427, PubMed:17329401, PubMed:9829974, PubMed:9878049). Also mediates arginine transport in non-polarized cells, such as monocytes, and is es

LOCALIZAÇÃO

Basolateral cell membrane

VIAS BIOLÓGICAS (2)
Basigin interactionsAmino acid transport across the plasma membrane
MECANISMO DE DOENÇA

Lysinuric protein intolerance

A metabolic disorder characterized by increased renal excretion of cationic amino acid (CAA), reduced CAA absorption from intestine, and orotic aciduria. On a normal diet, LPI patients present poor feeding, vomiting, diarrhea, episodes of hyperammoniaemic coma and growth retardation. Hepatosplenomegaly, osteoporosis and a life-threatening pulmonary involvement (alveolar proteinosis) are also seen. Biochemically LPI is characterized by defective transport of dibasic amino acids at the basolateral membrane of epithelial cells in kidney and intestine.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
60.0 TPM
Sangue
50.0 TPM
Testículo
38.5 TPM
Rim - Córtex
38.0 TPM
Intestino delgado
37.5 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
lysinuric protein intolerance
HGNC:11065UniProt:Q9UM01
TMEM216Transmembrane protein 216Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for primary ciliogenesis and embryonic development, facilitating the activation of Hedgehog (Hh) signaling pathway. Disrupts the interaction of GLI2 and GLI3 with the negative regulator SUFU. Inhibiting SUFU's interaction with GLI2 promotes the entry of GLI2 into the nucleus, allowing it to activate Hh target gene expression. Disrupting SUFU's interaction with GLI3 prevents its conversion into the repressor form, leading to increased nuclear GLI3 and enhanced Hh signaling. Required for

LOCALIZAÇÃO

MembraneCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 2

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
31.3 TPM
Pituitária
27.0 TPM
Cervix Endocervix
25.9 TPM
Cervix Ectocervix
24.7 TPM
Testículo
23.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 98Meckel syndrome, type 2Joubert syndrome 2Meckel syndrome
HGNC:25018UniProt:Q9P0N5
AGBL5Cytosolic carboxypeptidase-like protein 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Metallocarboxypeptidase that mediates deglutamylation of tubulin and non-tubulin target proteins. Catalyzes the removal of polyglutamate side chains present on the gamma-carboxyl group of glutamate residues within the C-terminal tail of alpha- and beta-tubulin. Cleaves alpha- and gamma-linked polyglutamate tubulin side-chain, as well as the branching point glutamate. Also catalyzes the removal of alpha-linked glutamate residues from the carboxy-terminus of alpha-tubulin. Mediates deglutamylation

LOCALIZAÇÃO

Cytoplasm, cytosolNucleusCytoplasm, cytoskeleton, spindleMidbody

VIAS BIOLÓGICAS (1)
Carboxyterminal post-translational modifications of tubulin
MECANISMO DE DOENÇA

Retinitis pigmentosa 75

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP75 inheritance is autosomal recessive.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 75retinitis pigmentosa
HGNC:26147UniProt:Q8NDL9
PDE6ARod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP (PubMed:20940301). This protein participates in processes of transmission and amplification of the visual signal

LOCALIZAÇÃO

Cell membraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Ca2+ pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 43

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.6 TPM
Pituitária
3.1 TPM
Esôfago - Mucosa
1.5 TPM
Cólon transverso
1.1 TPM
Glândula adrenal
0.8 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 43retinitis pigmentosa
HGNC:8785UniProt:P16499
RPE65Retinoid isomerohydrolaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Critical isomerohydrolase in the retinoid cycle involved in regeneration of 11-cis-retinal, the chromophore of rod and cone opsins. Catalyzes the cleavage and isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol which is further oxidized by 11-cis retinol dehydrogenase to 11-cis-retinal for use as visual chromophore (PubMed:16116091). Essential for the production of 11-cis retinal for both rod and cone photoreceptors (PubMed:17848510). Also capable of catalyzing the isomerizati

LOCALIZAÇÃO

CytoplasmCell membraneMicrosome membrane

VIAS BIOLÓGICAS (1)
The canonical retinoid cycle in rods (twilight vision)
MECANISMO DE DOENÇA

Leber congenital amaurosis 2

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Substância negra
4.6 TPM
Hipotálamo
2.6 TPM
Brain Spinal cord cervical c-1
0.8 TPM
Próstata
0.6 TPM
Hipocampo
0.5 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 20Leber congenital amaurosis 2retinitis pigmentosa 87 with choroidal involvementRPE65-related recessive retinopathy
HGNC:10294UniProt:Q16518
HKDC1Hexokinase HKDC1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the phosphorylation of hexose to hexose 6-phosphate, although at very low level compared to other hexokinases (PubMed:30517626). Has low glucose phosphorylating activity compared to other hexokinases (PubMed:30517626). Involved in glucose homeostasis and hepatic lipid accumulation. Required to maintain whole-body glucose homeostasis during pregnancy; however additional evidences are required to confirm this role (By similarity)

LOCALIZAÇÃO

CytoplasmMitochondrion membranePhotoreceptor inner segment

VIAS BIOLÓGICAS (1)
Glycolysis
MECANISMO DE DOENÇA

Retinitis pigmentosa 92

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP92 is an autosomal recessive, mild form with onset of night blindness and vision loss in the third to sixth decades of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
28.3 TPM
Rim - Medula
10.6 TPM
Rim - Córtex
10.1 TPM
Nervo tibial
9.8 TPM
Tireoide
5.6 TPM
OUTRAS DOENÇAS (1)
retinitis pigmentosa 92
HGNC:HGNC:23302UniProt:Q2TB90
ARL2BPADP-ribosylation factor-like protein 2-binding proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2

LOCALIZAÇÃO

CytoplasmMitochondrion intermembrane spaceCytoplasm, cytoskeleton, microtubule organizing center, centrosomeNucleusCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 82 with or without situs inversus

An autosomal recessive disorder characterized by variable association of retinitis pigmentosa with situs inversus. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. Situs inversus is a congenital abnormality in which organs in the thorax and the abdomen are opposite to their normal positions due to lateral transposition.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
retinitis pigmentosa with or without situs inversusretinitis pigmentosa
HGNC:17146UniProt:Q9Y2Y0
ROM1Rod outer segment membrane protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in rod outer segment (ROS) morphogenesis (By similarity). May play a role with PRPH2 in the maintenance of the structure of ROS curved disks (By similarity). Plays a role in the organization of the ROS and maintenance of ROS disk diameter (By similarity). Involved in the maintenance of the retina outer nuclear layer (By similarity)

LOCALIZAÇÃO

Photoreceptor inner segment membranePhotoreceptor outer segment membrane

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
56.0 TPM
Substância negra
34.4 TPM
Cérebro - Amígdala
24.2 TPM
Hipocampo
23.2 TPM
Cérebro - Hemisfério cerebelar
22.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 7retinitis pigmentosa
HGNC:10254UniProt:Q03395
CFAP418Cilia- and flagella-associated protein 418Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in photoreceptor outer segment disk morphogenesis (By similarity)

LOCALIZAÇÃO

CytoplasmPhotoreceptor inner segment

MECANISMO DE DOENÇA

Cone-rod dystrophy 16

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (5)
cone-rod dystrophy 16bardet-biedl syndrome 21cone-rod dystrophyretinitis pigmentosa
HGNC:27232UniProt:Q96NL8
IMPG2Interphotoreceptor matrix proteoglycan 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Chondroitin sulfate- and hyaluronan-binding proteoglycan involved in the organization of interphotoreceptor matrix; may participate in the maturation and maintenance of the light-sensitive photoreceptor outer segment. Binds heparin

LOCALIZAÇÃO

Photoreceptor outer segment membranePhotoreceptor inner segment membraneSecreted, extracellular space, extracellular matrix, interphotoreceptor matrix

MECANISMO DE DOENÇA

Retinitis pigmentosa 56

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Fallopian Tube
0.8 TPM
Rim - Medula
0.7 TPM
Artéria coronária
0.5 TPM
Nervo tibial
0.4 TPM
Baço
0.4 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 56vitelliform macular dystrophy 5retinitis pigmentosaadult-onset foveomacular vitelliform dystrophy
HGNC:18362UniProt:Q9BZV3
ABCA4Retinal-specific phospholipid-transporting ATPase ABCA4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leaflet of photoreceptor outer segment disk membranes, where 11-cis-retinylidene-phosphatidylethanolamine is then isomerized to its all-trans isomer and reduced by RDH8 to produce all-trans-retinol. This transport activity ensures that all-trans-retinal generated fr

LOCALIZAÇÃO

MembraneEndoplasmic reticulumCytoplasmic vesicleCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)ABC-family proteins mediated transport
MECANISMO DE DOENÇA

Stargardt disease 1

An autosomal recessive form of Stargardt disease, a retinal degenerative disease characterized by macular dystrophy, progressive bilateral atrophy of the foveal retinal pigment epithelium, and accumulation of fluorescent flecks around the macula and/or in the central and near-peripheral areas of the retina. STGD1 patients typically lose central vision in their first or second decade of life.

OUTRAS DOENÇAS (8)
severe early-childhood-onset retinal dystrophyretinitis pigmentosa 19cone-rod dystrophy 3ABCA4-related retinopathy
HGNC:34UniProt:P78363
GRID2Glutamate receptor ionotropic, delta-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Member of the ionotropic glutamate receptor family, which plays a crucial role in synaptic organization and signal transduction in the central nervous system. Although it shares structural features with ionotropic glutamate receptors, does not bind glutamate as a primary ligand (PubMed:34936451). Promotes synaptogenesis and mediates the D-Serine-dependent long term depression signals and AMPA receptor endocytosis of cerebellar parallel fiber-Purkinje cell (PF-PC) synapses through the NRX1B-CBLN1

LOCALIZAÇÃO

Postsynaptic cell membrane

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 18

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR18 features include progressive cerebellar atrophy, delayed psychomotor development, severely impaired gait, ocular movement abnormalities, and intellectual disability.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
10.4 TPM
Cérebro - Hemisfério cerebelar
7.5 TPM
Testículo
6.2 TPM
Brain Nucleus accumbens basal ganglia
1.8 TPM
Hipotálamo
1.6 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 18
HGNC:4576UniProt:O43424
RAX2Retina and anterior neural fold homeobox protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in modulating the expression of photoreceptor specific genes. Binds to the Ret-1 and Bat-1 element within the rhodopsin promoter

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Macular degeneration, age-related, 6

A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pituitária
1.9 TPM
Fallopian Tube
0.9 TPM
Útero
0.7 TPM
Cervix Endocervix
0.1 TPM
Testículo
0.1 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 95cone-rod dystrophy 11age related macular degeneration 6cone-rod dystrophy
HGNC:18286UniProt:Q96IS3
IFT140Intraflagellar transport protein 140 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs) (PubMed:20889716, PubMed:22503633). Plays a pivotal role in proper development and function of ciliated cells through its role in ciliogenesis and/or cilium maintenance (PubMed:22503633). Required for the development and maintenance of the outer segments of rod and cone photoreceptor cells. Plays a role in maintenance and the delivery of opsin to

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 9 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. SRTD9 is characterized by phalangeal cone-shaped epiphyses, chronic renal disease, nearly constant retinal dystrophy, and mild radiographic abnormality of the proximal femur. Occasional features include short stature, cerebellar ataxia, and hepatic fibrosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
59.8 TPM
Testículo
47.9 TPM
Pituitária
34.4 TPM
Ovário
31.1 TPM
Cervix Endocervix
29.6 TPM
OUTRAS DOENÇAS (8)
retinitis pigmentosa 80cranioectodermal dysplasia 5short-rib thoracic dysplasia 9 with or without polydactylyJeune syndrome
HGNC:29077UniProt:Q96RY7
PCAREPhotoreceptor cilium actin regulatorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays an essential role for normal photoreceptor cell maintenance and vision

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 54

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 54retinitis pigmentosa
HGNC:34383UniProt:A6NGG8
PRPF31U4/U6 small nuclear ribonucleoprotein Prp31Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11867543, PubMed:20118938, PubMed:28781166). Required for the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed:11867543)

LOCALIZAÇÃO

NucleusNucleus speckleNucleus, Cajal body

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 11

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
81.5 TPM
Útero
81.1 TPM
Fibroblastos
77.6 TPM
Linfócitos
76.5 TPM
Cervix Ectocervix
76.4 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 11retinitis pigmentosa
HGNC:15446UniProt:Q8WWY3
ARHGEF18Rho guanine nucleotide exchange factor 18Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPases. Its activation induces formation of actin stress fibers. Also acts as a GEF for RAC1, inducing production of reactive oxygen species (ROS). Does not act as a GEF for CDC42. The G protein beta-gamma (Gbetagamma) subunits of heterotrimeric G proteins act as activators, explaining the integrated effects of LPA and other G-protein coupled receptor agonists on actin stress fiber formation, cell shape change and ROS production. Requi

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCell membraneApical cell membrane

VIAS BIOLÓGICAS (1)
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
MECANISMO DE DOENÇA

Retinitis pigmentosa 78

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP78 inheritance is autosomal recessive.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 78retinitis pigmentosa
HGNC:17090UniProt:Q6ZSZ5
KIZCentrosomal protein kizunaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Centrosomal protein required for establishing a robust mitotic centrosome architecture that can endure the forces that converge on the centrosomes during spindle formation. Required for stabilizing the expanded pericentriolar material around the centriole

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal body

MECANISMO DE DOENÇA

Retinitis pigmentosa 69

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
60.4 TPM
Cervix Endocervix
50.2 TPM
Cervix Ectocervix
38.4 TPM
Ovário
36.5 TPM
Bladder
35.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 69retinitis pigmentosa
HGNC:15865UniProt:Q2M2Z5
SLC7A14Solute carrier family 7 member 14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Imports 4-aminobutanoate (GABA) into lysosomes. May act as a GABA sensor that regulates mTORC2-dependent INS signaling and gluconeogenesis. The transport mechanism and substrate selectivity remain to be elucidated

LOCALIZAÇÃO

Lysosome membrane

MECANISMO DE DOENÇA

Retinitis pigmentosa 68

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
21.6 TPM
Cerebelo
15.0 TPM
Pituitária
14.2 TPM
Hipotálamo
9.8 TPM
Brain Spinal cord cervical c-1
9.2 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 68retinitis pigmentosa
HGNC:29326UniProt:Q8TBB6
ARL6ADP-ribosylation factor-like protein 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in membrane protein trafficking at the base of the ciliary organelle. Mediates recruitment onto plasma membrane of the BBSome complex which would constitute a coat complex required for sorting of specific membrane proteins to the primary cilia (PubMed:20603001). Together with BBS1, is necessary for correct trafficking of PKD1 to primary cilia (By similarity). Together with the BBSome complex and LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 3

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (5)
retinitis pigmentosa 55Bardet-Biedl syndrome 3retinitis pigmentosaBardet-Biedl syndrome
HGNC:13210UniProt:Q9H0F7
RHORhodopsinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Photoreceptor required for image-forming vision at low light intensity (PubMed:7846071, PubMed:8107847). Required for photoreceptor cell viability after birth (PubMed:12566452, PubMed:2215617). Light-induced isomerization of the chromophore 11-cis-retinal to all-trans-retinal triggers a conformational change that activates signaling via G-proteins (PubMed:26200343, PubMed:28524165, PubMed:28753425, PubMed:8107847). Subsequent receptor phosphorylation mediates displacement of the bound G-protein

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (4)
OpsinsG alpha (i) signalling eventsThe canonical retinoid cycle in rods (twilight vision)Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 4

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
0.5 TPM
Cerebelo
0.5 TPM
Cérebro - Hemisfério cerebelar
0.5 TPM
Córtex cerebral
0.5 TPM
Testículo
0.2 TPM
OUTRAS DOENÇAS (6)
retinitis pigmentosa 4fundus albipunctatuscongenital stationary night blindness autosomal dominant 1retinitis pigmentosa
HGNC:10012UniProt:P08100
USH2AUsherinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in hearing and vision as member of the USH2 complex. In the inner ear, required for the maintenance of the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport

LOCALIZAÇÃO

Cell projection, stereocilium membraneSecreted

MECANISMO DE DOENÇA

Usher syndrome 2A

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.2 TPM
Fígado
0.8 TPM
Cérebro - Hemisfério cerebelar
0.2 TPM
Cerebelo
0.2 TPM
Coração - Átrio
0.2 TPM
OUTRAS DOENÇAS (5)
retinitis pigmentosa 39Usher syndrome type 2AUsher syndromeretinitis pigmentosa
HGNC:12601UniProt:O75445
TOPORSE3 ubiquitin-protein ligase ToporsDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions as an E3 ubiquitin-protein ligase and as an E3 SUMO1-protein ligase. Probable tumor suppressor involved in cell growth, cell proliferation and apoptosis that regulates p53/TP53 stability through ubiquitin-dependent degradation. May regulate chromatin modification through sumoylation of several chromatin modification-associated proteins. May be involved in DNA damage-induced cell death through IKBKE sumoylation

LOCALIZAÇÃO

NucleusNucleus, PML body

VIAS BIOLÓGICAS (3)
SUMOylation of immune response proteinsSUMOylation of transcription cofactorsSUMOylation of SUMOylation proteins
MECANISMO DE DOENÇA

Retinitis pigmentosa 31

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
31.6 TPM
Ovário
23.5 TPM
Fibroblastos
21.4 TPM
Fallopian Tube
18.9 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 31retinitis pigmentosaorofaciodigital syndrome type 6
HGNC:21653UniProt:Q9NS56

Variantes genéticas (ClinVar)

785 variantes patogênicas registradas no ClinVar.

🧬 PRPH2: NM_000322.5(PRPH2):c.495C>G (p.Cys165Trp) ()
🧬 PRPH2: NM_000322.5(PRPH2):c.520T>G (p.Trp174Gly) ()
🧬 PRPH2: NM_000322.5(PRPH2):c.629C>A (p.Pro210His) ()
🧬 PRPH2: NM_000322.5(PRPH2):c.291G>A (p.Trp97Ter) ()
🧬 PRPH2: NM_000322.5(PRPH2):c.219_220insAA (p.Phe74fs) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

125 vias biológicas associadas aos genes desta condição.

Insulin processing Interaction between L1 and Ankyrins Phase 0 - rapid depolarisation Voltage gated Potassium channels Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Mechanical load activates signaling by PIEZO1 and integrins in osteocytes Golgi Associated Vesicle Biogenesis Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Toll Like Receptor 4 (TLR4) Cascade Retrograde neurotrophin signalling Gap junction degradation Formation of annular gap junctions MHC class II antigen presentation EPH-ephrin mediated repulsion of cells Recycling pathway of L1 Stimuli-sensing channels BBSome-mediated cargo-targeting to cilium Hedgehog 'off' state Intraflagellar transport Activation of the phototransduction cascade Inactivation, recovery and regulation of the phototransduction cascade Ca2+ pathway PPARA activates gene expression Phase I - Functionalization of compounds Endogenous sterols Xenobiotics Aryl hydrocarbon receptor signalling Amino acid transport across the plasma membrane SLC-mediated transport of neurotransmitters Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) Activation of BAD and translocation to mitochondria Translocation of SLC2A4 (GLUT4) to the plasma membrane Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane RHO GTPases activate PKNs TP53 Regulates Metabolic Genes Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex AURKA Activation by TPX2 Regulation of localization of FOXO transcription factors SARS-CoV-1 targets host intracellular signalling and regulatory pathways SARS-CoV-2 targets host intracellular signalling and regulatory pathways Transcriptional and post-translational regulation of MITF-M expression and activity SPOP-mediated proteasomal degradation of PD-L1(CD274) Amino acids regulate mTORC1 ROS and RNS production in phagocytes Insulin receptor recycling Transferrin endocytosis and recycling Ion channel transport Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy Cell surface interactions at the vascular wall Dengue Virus Attachment and Entry RP105:MD1 Defective SLC3A1 causes cystinuria (CSNU) Defective SLC7A9 causes cystinuria (CSNU) NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux Diseases of branched-chain amino acid catabolism PTEN Regulation Regulation of PTEN gene transcription FCERI mediated NF-kB activation Stabilization of p53 Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) Regulation of TP53 Activity through Phosphorylation TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway mRNA Splicing - Major Pathway mRNA Splicing - Minor Pathway Dengue Virus-Host Interactions G alpha (q) signalling events Class C/3 (Metabotropic glutamate/pheromone receptors) Neurexins and neuroligins Sensory perception of sweet, bitter, and umami (glutamate) taste Glutamate Neurotransmitter Release Cycle Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) SLC-mediated transport of amino acids RPGRIP1L RAB8A,10,13,14 exchange GDP for GTP Defective SLC6A19 causes Hartnup disorder (HND) Defective SLC6A19 causes Hartnup disorder (HND) Presynaptic depolarization and calcium channel opening Regulation of insulin secretion SLC-mediated transport of organic anions HCN channels Synthesis of PIPs at the plasma membrane Synthesis of PIPs at the Golgi membrane Synthesis of IP2, IP, and Ins in the cytosol Synthesis of IP3 and IP4 in the cytosol RHOJ GTPase cycle RAC3 GTPase cycle Basigin interactions Miscellaneous transport and binding events SLC-mediated transport of oligopeptides Signaling by ERBB4 GABA receptor activation Eukaryotic Translation Elongation Citric acid cycle (TCA cycle) Mitochondrial protein degradation HS-GAG degradation MPS IIIC - Sanfilippo syndrome C Neutrophil degranulation Synthesis of dolichyl-phosphate Defective DHDDS causes RP59 Defective SLC7A7 causes lysinuric protein intolerance (LPI) Carboxyterminal post-translational modifications of tubulin The canonical retinoid cycle in rods (twilight vision) Glycolysis Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane ABC-family proteins mediated transport Defective visual phototransduction due to ABCA4 loss of function NRAGE signals death through JNK TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) G alpha (12/13) signalling events RHOA GTPase cycle RAC1 GTPase cycle Transphosphorylation of pLIMK1 G alpha (i) signalling events Opsins VxPx cargo-targeting to cilium SUMOylation of transcription cofactors SUMOylation of SUMOylation proteins SUMOylation of immune response proteins

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença do transporte de aminoácidos

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Comparative cytotoxicity of novel mercury species α-mercuri-acetaldehyde and α-mercuri-acetic acid versus methylmercury in SH-SY5Y cells.

The Journal of toxicological sciences2026

Recently, α-mercuri-acetaldehyde (HgCH2CHO) and α-mercuri-acetic acid (HgCH2COOH) have been proposed as potential causative agents of Minamata disease. However, their toxicological profiles remain largely unknown. This study aimed to characterize the cytotoxicity, cellular uptake, and efflux mechanisms of these compounds in SH-SY5Y neuroblastoma cells and to compare these properties with those of methylmercury (MeHg). Cell viability was assessed after 24 hr of exposure to MeHg (1-10 µM), HgCH2CHO (10-50 µM), or HgCH2COOH (10-50 µM) using the CCK-8 assay. The roles of L-type amino acid transporter 1 (LAT1) and multidrug resistance-associated proteins (MRPs) were evaluated using the inhibitors JPH203 (1 µM) and MK571 (10 µM), respectively. Intracellular mercury accumulation was quantified after 24 hr of exposure to 3 µM of each compound using thermal decomposition-amalgamation atomic absorption spectrometry. All compounds exhibited dose-dependent cytotoxicity, with a relative toxicity order of MeHg (LC50: 6.4 µM) > HgCH2CHO (LC50: 14.6 µM) > HgCH2COOH (LC50: 39.2 µM). LAT1 inhibition had minimal effect on MeHg toxicity but slightly attenuated that of HgCH2CHO and HgCH2COOH. Conversely, MRP inhibition markedly enhanced MeHg toxicity, modestly increased that of HgCH2CHO, and slightly increased that of HgCH2COOH. Cellular mercury accumulation was consistent with cytotoxicity patterns, showing 10-20-fold lower levels for HgCH2CHO and HgCH2COOH than for MeHg. HgCH2CHO and HgCH2COOH were approximately 2-5-fold less cytotoxic than MeHg and exhibited substantially lower intracellular mercury levels. Our findings suggest that HgCH2CHO and HgCH2COOH are unlikely to have neurotoxic potential comparable to that of MeHg.

#2

TMAO converts cytochrome c into a pro-apoptotic peroxidase by destabilizing the heme-Met80 ligation.

Cellular and molecular biology (Noisy-le-Grand, France)2025 Dec 28

Trimethylamine N-oxide (TMAO), a gut microbiota-derived metabolite, has been linked to cardiovascular, renal, and hepatic disorders, but its direct impact on mitochondrial apoptotic machinery remains unclear. Here, we show that TMAO binds cytochrome c (Cyt c), disrupting its structural integrity and converting it into an apoptotically competent species. Spectroscopic analyses revealed that TMAO destabilizes the heme-Met80 axial ligation, shifting Cyt c from its native hexacoordinate to a pentacoordinate state. This conformational change enhances peroxidase activity, exposes hydrophobic clusters, and perturbs the Trp microenvironment, marking Cyt c's transition from electron carrier to pro-apoptotic catalyst. Absorption spectra further showed splitting of the native 530 nm band into peaks at 520 and 550 nm, consistent with heme reduction. These alterations facilitate Cyt c release from the mitochondrial membrane and engagement in intrinsic apoptosis. Given that TMAO accumulates at higher concentrations in tissues enriched with oxygen transporters, such as kidney and liver, our findings provide mechanistic insight into its role in organ-specific toxicity, including chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD). This study establishes a direct molecular link between TMAO and mitochondrial apoptosis via Cyt c destabilization, suggesting that stabilizing Cyt c could represent a therapeutic strategy against TMAO-associated pathologies.

#3

Hartnup disease-causing SLC6A19 mutations lead to B0AT1 aberrant trafficking and ACE2 mis-localisation implicating the endoplasmic reticulum protein quality control.

Frontiers in cell and developmental biology2025

The interaction between angiotensin-converting enzyme 2 (ACE2) and the sodium-dependent Broad neutral Amino acid Transporter 1 (B0AT1), encoded by the SLC6A19 gene, is increasingly recognized as pivotal in both physiological and pathological contexts. B0AT1 facilitates neutral amino acid transport and nutrient absorption, while ACE2 regulates vascular homeostasis and inflammation through the renin-angiotensin system. Mutations in SLC6A19 are implicated in Hartnup disease, a metabolic disorder characterized by defective amino acid transport. However, the cellular mechanisms underlying Hartnup disease-causing mutations' impact on B0AT1 and ACE2 function remain unclear. This study evaluated the subcellular localization and trafficking of 18 Hartnup disease-causing B0AT1 variants using experimental approaches including biochemical assays and In Silico analysis. The impact of these variants on ACE2 trafficking and plasma membrane targeting was also assessed to elucidate their interplay. Nine B0AT1 variants (R57C, G93R, R95P, R178Q, L242P, G284R, S303L, D517G, P579L) were found to be retained in the endoplasmic reticulum, impairing their trafficking to the plasma membrane. These variants were distributed across multiple B0AT1 structural domains. Importantly, several of these ER-retained variants, particularly R178Q and S303L, significantly disrupted ACE2 intracellular trafficking and its localization to the plasma membrane, indicating a direct effect on ACE2 subcellular targeting. The findings reveal that Hartnup disease-causing mutations can lead to ER retention of B0AT1, which in turn has a variable effect on ACE2 trafficking. This disruption likely contributes to Hartnup disease pathogenesis by impairing amino acid transport and may influence ACE2-mediated physiological functions beyond the renin-angiotensin system. Understanding these molecular mechanisms enhances insight into ACE2-B0AT1 interactions and could inform future therapeutic strategies and biomarker development for related disorders. Further research is needed to explore these pathways and their implications in disease.

#4

Acute MK-801 induces hyperactivity and changes spatio-temporal exploratory dynamics without disrupting homebase retention in adult zebrafish.

Behavioural brain research2025 Oct 18

The N-methyl-D-aspartate receptor (NMDAR) antagonist dizocilpine (MK-801) modulates locomotor functions and disrupts cognitive and spatial processes, making it useful for examining pharmacologically-induced behavioral phenotypes that mimic schizophrenia. Here, we investigated the impact of MK-801 on spatio-temporal exploratory dynamics in adult zebrafish, focusing on homebase behavior in the open field test (OFT). In Experiment 1, zebrafish received an intraperitoneal (i.p.) injection of saline or MK-801 (2.0 mg/kg), followed by a 15-min absorption period prior to a 30-min OFT. Experiment 2 involved an initial 30-min OFT, immediate saline or MK-801 (2.0 mg/kg), i.p. administration, and a retrial in the OFT 24 h later. Overall, MK-801 induced hyperactivity and stereotypy in Experiment 1. Although zebrafish were able to establish a homebase as a functionally relevant spatial reference, notable alterations in homebase-related behaviors were observed. Experiment 2 explored the homebase conservation across repeated OFT sessions, revealing that despite subtle changes in overall exploration and homebase occupancy, both groups demonstrated significant homebase conservation and reduced thigmotaxis in the retrial. An inhibitory avoidance task was also performed to confirm the amnesic effects of MK-801 on zebrafish (Experiment 3), revealing impaired aversive memory consolidation. Our novel findings indicate that while MK-801 altered movement patterns and disrupted aversive memory, zebrafish core spatial behaviors remained intact, highlighting the adaptive value of homebase as a conserved spatial strategy. Collectively, this work further supports the utility of zebrafish models for studying how pharmacological modulations of NMDAR affect spatial orientation and exploratory behavior, with translational relevance to neuropsychiatric diseases.

#5

Pitfalls in the Diagnosis of Wilson Disease.

Current neurology and neuroscience reports2025 Jun 12

Wilson disease (WD), an uncommon autosomal recessive (AR) hereditary disorder characterized by abnormal accumulation of copper primarily in the liver and secondarily in other organs like the brain, is caused by a deficiency in the ATP7B transporter gene. The key to successful therapy is early diagnosis. Mutant genes need to be inherited from both parents for phenotypic expression. The ATP7B gene located on chromosome 13q14.3 comprises 20 introns and 21 exons, encodes a protein of 165 amino acids, and this helps in incorporation of copper into ceruloplasmin, the copper binding protein. So far, more than 800 mutations have been reported, of which 380 have confirmed involvement in the pathogenesis of WD. The most common mutations are H1069Q and R778L in European and Asian populations respectively. Approximately 90%-98% of WD subjects are heterozygous, showing different mutations in each of the alleles encoding the ATP7B. Conversely, the phenotype and the penetrance of WD can be extremely variable. Even patients carrying two disease-causing mutations do not necessarily have a demonstrable alteration of copper metabolism. Considering the possibility of late-onset disease, asymptomatic cases, and phenotypic variability, it is crucial to evaluate previous and future generations of the index case. WD ranges from being asymptomatic in some patients to result in acute liver failure and/or a variety of neuropsychiatric disorders among others. Although WD may be present at any age, is more common between the ages of 5 and 35 years. However, it should be investigated in patients with liver failure of unknown cause and those with liver disease associated with neuropsychiatric symptomatology. Diagnosis requires a combination of clinical signs and symptoms, as well as relevant diagnostic tests such as measurement of serum ceruloplasmin, urinary excretion of copper, liver biopsy or genetic testing. Treatment is lifelong and includes chelating agents (penicillamine and trientine) and inhibitors of copper absorption (zinc salts). Liver transplant is an option for patients with end-stage liver disease. The key to successful therapy is early diagnosis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Comparative cytotoxicity of novel mercury species α-mercuri-acetaldehyde and α-mercuri-acetic acid versus methylmercury in SH-SY5Y cells.

The Journal of toxicological sciences
2025

A Rare Case of Congenital Glucose Galactose Malabsorption Due to SLC5A1 Mutation.

Cureus
2025

TMAO converts cytochrome c into a pro-apoptotic peroxidase by destabilizing the heme-Met80 ligation.

Cellular and molecular biology (Noisy-le-Grand, France)
2025

Glucagon-like peptide-1 receptor agonists and risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulation.

Cardiovascular diabetology
2025

[Exploring the potential causes of sarcopenia in sepsis patients based on proteome sequencing].

Zhonghua wei zhong bing ji jiu yi xue
2025

Case report: Lysine improvement in siblings with glutaric acidemia type 1 following reduced medical food intake: Implications for amino acid absorption and reabsorption.

Molecular genetics and metabolism reports
2025

Hartnup disease-causing SLC6A19 mutations lead to B0AT1 aberrant trafficking and ACE2 mis-localisation implicating the endoplasmic reticulum protein quality control.

Frontiers in cell and developmental biology
2025

Acute MK-801 induces hyperactivity and changes spatio-temporal exploratory dynamics without disrupting homebase retention in adult zebrafish.

Behavioural brain research
2025

Amino acids critical for lipid/s-interaction at the lipid-water-interface of TRPV5/TRPV6 remain different during vertebrate radiation: Relevance in cancer, bone disorders and other pathophysiologies.

Biochimica et biophysica acta. Biomembranes
2025

Ergothioneine as a functional nutraceutical: Mechanisms, bioavailability, and therapeutic implications.

The Journal of nutritional biochemistry
2025

Pitfalls in the Diagnosis of Wilson Disease.

Current neurology and neuroscience reports
2025

Single Amino Acid Supplementation in Inherited Metabolic Disorders: An Evidence-Based Review of Interventions.

Genes
2025

Gly-βMCA modulates bile acid metabolism to reduce hepatobiliary injury in Mdr2 KO mice.

American journal of physiology. Gastrointestinal and liver physiology
2025

Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver disease.

Gut microbes
2025

Identification of a Novel NPC1L1 Inhibitor from Danshen and Its Role in Nonalcoholic Fatty Liver Disease.

International journal of molecular sciences
2025

Gestational exposure to polystyrene microplastics incurred placental damage in mice: Insights into metabolic and gene expression disorders.

Ecotoxicology and environmental safety
2025

Inherited disorders of vitamin metabolism.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2025

Aromatic Amino Acid Metabolites: Molecular Messengers Bridging Immune-Microbiota Communication.

Immune network
2025

Transcriptome and metabolome analysis reveal the mechanisms of iron absorption differences in apple rootstocks under alkaline condition.

Physiologia plantarum
2025

Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice With Mitoxantrone-Induced Cardiotoxicity.

Drug design, development and therapy
2025

Design of (R)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific Activity.

Journal of medicinal chemistry
2025

Conversion of α-linolenic acid into n-3 long-chain polyunsaturated fatty acids: bioavailability and dietary regulation.

Critical reviews in food science and nutrition
2024

Banxia-Yiyiren alleviates insomnia and anxiety by regulating the gut microbiota and metabolites of PCPA-induced insomnia model rats.

Frontiers in microbiology
2024

SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanine.

JCI insight
2024

Intestinal transport of organic food compounds and drugs: A scoping review on the alterations observed in chronic kidney disease.

Clinical nutrition ESPEN
2025

Mammalian colonic contribution of amino acids to whole-body homeostasis.

Current opinion in clinical nutrition and metabolic care
2024

Exopeptidase combination enhances the degradation of isotopically labelled gluten immunogenic peptides in humans.

Frontiers in immunology
2024

Bacillus CotA laccase improved the intestinal health, amino acid metabolism and hepatic metabolic capacity of Pekin ducks fed naturally contaminated AFB1 diet.

Journal of animal science and biotechnology
2025

Dietary protein intake and the tubular handling of indoxyl sulfate.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2024

Causes of difficulties with adequate levothyroxine substitution - an immunoendocrine perspective.

Endokrynologia Polska
2024

Zearalenone-induced hepatointestinal toxicity in laying hens: unveiling the role of gut microbiota and fecal metabolites.

Poultry science
2024

Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson's Disease.

Journal of Parkinson's disease
2024

Molecular basis of inhibition of the amino acid transporter B0AT1 (SLC6A19).

Nature communications
2024

Dietary Exposure to Acrylamide Has Negative Effects on the Gastrointestinal Tract: A Review.

Nutrients
2024

Multiomics reveals the ameliorating effect and underlying mechanism of aqueous extracts of polygonatum sibiricum rhizome on obesity and liver fat accumulation in high-fat diet-fed mice.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2024

Investigation on the mechanisms of scorpion venom in hepatocellular carcinoma model mice via untargeted metabolomics profiling.

International immunopharmacology
2024

Improvement of in vivo iron bioavailability using mung bean peptide-ferrous chelate.

Food research international (Ottawa, Ont.)
2024

Increased Absorption of Thyroxine in a Murine Model of Hypothyroidism Using Water/CO2 Nanobubbles.

International journal of molecular sciences
2024

The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1.

Metabolism: clinical and experimental
2024

Comparative genomic and metabolomic analysis reveals the potential of a newly isolated Enterococcus faecium B6 involved in lipogenic effects.

Gene
2024

Multi-target Phenylpropanoids Against Epilepsy.

Current neuropharmacology
2024

Inflammation and Organic Cation Transporters Novel (OCTNs).

Biomolecules
2024

N-acetylcysteine absorption and its potential dual effect improve fitness and fruit yield in Xylella fastidiosa infected plants.

Pest management science
2024

Myricanol improves metabolic profiles in dexamethasone induced lipid and protein metabolism disorders in mice.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2024

Mechanisms of Dangua Fang in multi-target and multi-method regulation of glycolipid metabolism based on phosphoproteomics.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
2024

Sporisorium reilianum polysaccharides improve DSS-induced ulcerative colitis by regulating intestinal barrier function and metabolites.

International journal of biological macromolecules
2024

A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome.

Expert opinion on drug metabolism & toxicology
2024

Role of zinc in health and disease.

Clinical and experimental medicine
2024

Important nutrient sources and carbohydrate metabolism patterns in the growth and development of spargana.

Parasites & vectors
2024

Vitamin K (Menadione)-incorporated chitosan/alginate hydrogel as a novel product for periorbital hyperpigmentation.

Journal of biomaterials science. Polymer edition
2024

Traditional Chinese Medicine formula Dai-Zong-Fang alleviating hepatic steatosis in db/db mice via gut microbiota modulation.

Frontiers in pharmacology
2023

Gut microbiota and metabolic profiles in chronic intermittent hypoxia-induced rats: disease-associated dysbiosis and metabolic disturbances.

Frontiers in endocrinology
2024

A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustat.

Journal of nephrology
2023

Ergothioneine: an underrecognised dietary micronutrient required for healthy ageing?

The British journal of nutrition
2023

The SLC6A15-SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance.

Pharmacological reviews
2023

Evaluation of thiadiazine-based PET radioligands for imaging the AMPA receptor.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2023

Integration of 16S rRNA gene sequencing and LC/MS-based metabolomic analysis of early biomarkers of acute ischaemic stroke in Tibetan miniature pigs.

Journal of microbiological methods
2024

Integrated analysis of metabolomic and transcriptomic profiling reveals the effect of Atractylodes oil on Spleen Yang Deficiency Syndrome in rats.

Journal of ethnopharmacology
2023

Rebalancing of mitochondrial homeostasis through an NAD+-SIRT1 pathway preserves intestinal barrier function in severe malnutrition.

EBioMedicine
2023

Serum and urine metabolomics study revealed the amelioration of Gynura bicolor extract on high fat diet-fed and streptozotocin-induced type 2 diabetic mice based on UHPLC-MS/MS.

Journal of pharmaceutical and biomedical analysis
2023

Refractory Hypothyroidism: Unraveling the Complexities of Diagnosis and Management.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2023

Amino acids contribute to adaptive thermogenesis. New insights into the mechanisms of action of recent drugs for metabolic disorders are emerging.

Pharmacological research
2023

Lysinuric protein intolerance presenting as pancytopenia and splenomegaly mimicking acute leukaemia: a case report.

BMC pediatrics
2024

Exploration of selected monoterpenes as potential TRPC channel family modulator in lung cancer, an in-silico upshot.

Journal of biomolecular structure & dynamics
2024

An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents.

Journal of biomolecular structure & dynamics
2023

A novel SLC5A6 homozygous variant in a family with multivitamin-dependent neurometabolic disorder: Phenotype expansion and long-term follow-up.

European journal of medical genetics
2023

A combined proteomics and metabolomics analysis reveals the invisible regulation of plant root responses to oxybenzone (benzophenone-3) stress.

The Science of the total environment
2023

Comprehensive expression analysis reveals several miRNAs against acute pancreatitis via modulating autophagy.

Cellular and molecular biology (Noisy-le-Grand, France)
2023

Comprehensive Proteome and Acetyl-Proteome Atlas Reveals Hepatic Lipid Metabolism in Layer Hens with Fatty Liver Hemorrhagic Syndrome.

International journal of molecular sciences
2023

Molecular mechanisms involved in fetal programming and disease origin in adulthood.

Journal of pediatric endocrinology & metabolism : JPEM
2023

Apolipoprotein E (APOE) Haplotypes in Healthy Subjects from Worldwide Macroareas: A Population Genetics Perspective for Cardiovascular Disease, Neurodegeneration, and Dementia.

Current issues in molecular biology
2023

Milk protects against sarcopenic obesity due to increase in the genus Akkermansia in faeces of db/db mice.

Journal of cachexia, sarcopenia and muscle
2023

New aspects for the brain in Hartnup disease based on mining of high-resolution cellular mRNA expression data for SLC6A19.

IBRO neuroscience reports
2023

The Influence of Alcohol Consumption on Intestinal Nutrient Absorption: A Comprehensive Review.

Nutrients
2023

Temporal Proteomic and Lipidomic Profiles of Cerulein-Induced Acute Pancreatitis Reveal Novel Insights for Metabolic Alterations in the Disease Pathogenesis.

ACS omega
2023

Cecal Microbial Succession and Its Apparent Association with Nutrient Metabolism in Broiler Chickens.

mSphere
2023

Therapeutic effect and mechanism of Daikenchuto in a model of methotrexate-induced acute small intestinal mucositis.

PloS one
2023

Dietary advanced glycation end products (dAGEs): An insight between modern diet and health.

Food chemistry
2023

Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease.

European journal of neurology
2023

Virtual screening and activity evaluation of human uric acid transporter 1 (hURAT1) inhibitors.

RSC advances
2023

Wilson's disease: overview.

Medicina clinica
2022

Contributions of SGK3 to transporter-related diseases.

Frontiers in cell and developmental biology
2022

Enhancing Mechanisms of the Plant Growth-Promoting Bacterial Strain Brevibacillus sp. SR-9 on Cadmium Enrichment in Sweet Sorghum by Metagenomic and Transcriptomic Analysis.

International journal of environmental research and public health
2023

COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics.

Drug metabolism and disposition: the biological fate of chemicals
2022

Proteome Analysis of Temporomandibular Joint with Disc Displacement.

Journal of dental research
2023

Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency.

Journal of inherited metabolic disease
2022

Systemic tryptophan homeostasis.

Frontiers in molecular biosciences
2022

Nontargeted metabolomics to characterize the effects of isotretinoin on skin metabolism in rabbit with acne.

Frontiers in pharmacology
2022

Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B0AT1 (Slc6a19).

American journal of physiology. Renal physiology
2022

Synthesis of 2-Acetamido-1,3,4-Tri-O-Acetyl-2-Deoxy-D-Mannopyranose -6-Phosphate Prodrugs as Potential Therapeutic Agents.

Current protocols
2022

An emerging role of vitamin D3 in amino acid absorption in different intestinal segments of on-growing grass carp (Ctenopharyngodon idella).

Animal nutrition (Zhongguo xu mu shou yi xue hui)
2022

Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction.

Nature biomedical engineering
2022

Metabolomics Study Suggests the Mechanism of Different Types of Tieguanyin (Oolong) Tea in Alleviating Alzheimer's Disease in APP/PS1 Transgenic Mice.

Metabolites
2022

Clinical and Genetic Analysis of a Family With Sitosterolemia Caused by a Novel ATP-Binding Cassette Subfamily G Member 5 Compound Heterozygous Mutation.

Frontiers in cardiovascular medicine
2022

Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats.

Frontiers in pharmacology
2022

Functional roles of taurine, L-theanine, L-citrulline, and betaine during heat stress in poultry.

Journal of animal science and biotechnology
2022

Modulation of Naturally Occurring Linear Dipeptide Chirality to Reduce the Affinity for Oligopeptide Transporter 1 and Increase Intestinal Stability for an Enhanced Colon-Targeting Effect in the Treatment of Inflammatory Bowel Disease: An Application of trans-4-l-Hydroxyprolyl-l-serine.

Journal of medicinal chemistry
2022

Chandamarutha Chenduram, an Indian traditional Siddha preparation attenuated the neuronal degeneration in ischemic mice through ameliorating cytokines and oxy-radicals mediated EAAT-2 dysfunction.

Journal of ethnopharmacology
2022

Fluorinated dihydropyridines as candidates to block L-type voltage-dependent calcium channels.

Journal of biomolecular structure & dynamics
2022

Recent advances in riboflavin transporter RFVT and its genetic disease.

Pharmacology & therapeutics
2021

Anaplasma phagocytophilum Hijacks Flotillin and NPC1 Complex To Acquire Intracellular Cholesterol for Proliferation, Which Can Be Inhibited with Ezetimibe.

mBio
2021

Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma.

JCI insight
2021

Decreased Expression of Ileal Thyroid Hormone Transporters in a Hypothyroid Patient: A Case Report.

Frontiers in endocrinology
2021

Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
2021

Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation.

Inflammatory bowel diseases
2021

Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.

Cellular and molecular gastroenterology and hepatology
2021

Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2.

Annals of neurology
2021

Zinc transporter mutations linked to acrodermatitis enteropathica disrupt function and cause mistrafficking.

The Journal of biological chemistry
2021

An Update on Evaluation and Management in Cystinuria.

Urology
2021

ATB0,+-targeted delivery of triptolide prodrugs for safer and more effective pancreatic cancer therapy.

Bioorganic & medicinal chemistry letters
2021

Clinical and molecular characterization of the R751L-CFTR mutation.

American journal of physiology. Lung cellular and molecular physiology
2020

Encapsulated crystalline lysine and DL-methionine have higher efficiency than the crystalline form in broilers.

Poultry science
2020

ACE2 and gut amino acid transport.

Clinical science (London, England : 1979)
2020

Hybridization of Curcumin Analogues with Cinnamic Acid Derivatives as Multi-Target Agents Against Alzheimer's Disease Targets.

Molecules (Basel, Switzerland)
2020

Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.

Inflammatory bowel diseases
2020

Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption.

CPT: pharmacometrics & systems pharmacology
2020

Use of encapsulated L-lysine-HCl and DL-methionine improves postprandial amino acid balance in laying hens.

Journal of animal science
2020

Effects of titanium dioxide nanoparticles on nutrient absorption and metabolism in rats: distinguishing the susceptibility of amino acids, metal elements, and glucose.

Nanotoxicology
2020

Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring.

Cells
2020

The leaves of Bougainvillea spectabilis suppressed inflammation and nociception in vivo through the modulation of glutamatergic, cGMP, and ATP-sensitive K+ channel pathways.

Journal of ethnopharmacology
2020

Postnatal growth retardation is associated with intestinal mucosa mitochondrial dysfunction and aberrant energy status in piglets.

Journal of cellular and molecular medicine
2020

Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.

The Journal of pharmacology and experimental therapeutics
2020

Cinnamaldehyde improves the growth performance and digestion and absorption capacity in grass carp (Ctenopharyngodon idella).

Fish physiology and biochemistry
2020

Proteomic and metabolomic characterization of cardiac tissue in acute myocardial ischemia injury rats.

PloS one
2020

Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.

Molecules (Basel, Switzerland)
2021

In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel.

Journal of biomolecular structure & dynamics
2020

The dynamic process of dietary soybean β-conglycinin in digestion, absorption, and metabolism among different intestinal segments in grass carp (Ctenopharyngodon idella).

Fish physiology and biochemistry
2020

Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer's Disease.

Molecular pharmaceutics
2020

Discovery of Potential Species-Specific Green Insecticides Targeting the Lepidopteran Ryanodine Receptor.

Journal of agricultural and food chemistry
2020

An unusually high plasma concentration of homocysteine resulting from a combination of so-called "secondary" etiologies.

Clinical biochemistry
2020

Mechanisms of Regulation of Transporters of Amino Acid Absorption in Inflammatory Bowel Diseases.

Comprehensive Physiology
2020

Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.

Frontiers in medicine
2020

Effects of glucocorticoids on the gene expression of nutrient transporters in different rabbit intestinal segments.

Animal : an international journal of animal bioscience
2020

Dietary protein-bound or free amino acids differently affect intestinal morphology, gene expression of amino acid transporters, and serum amino acids of pigs exposed to heat stress.

Journal of animal science
2020

Analysis of the relationship between the mutation site of the SLC39A4 gene and acrodermatitis enteropathica by reporting a rare Chinese twin: a case report and review of the literature.

BMC pediatrics
2019

Computational Modeling Explains the Multi Sterol Ligand Specificity of the N-Terminal Domain of Niemann-Pick C1-Like 1 Protein.

ACS omega
2020

y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.

Journal of cellular and molecular medicine
2019

Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Frontiers in neurology
2019

Effect of Euphorbia factor L1 on intestinal barrier impairment and defecation dysfunction in Caenorhabditis elegans.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2019

Improving Eflornithine Oral Bioavailability and Brain Uptake by Modulating Intercellular Junctions With an E-cadherin Peptide.

Journal of pharmaceutical sciences
2019

Mice Lacking the Intestinal and Renal Neutral Amino Acid Transporter SLC6A19 Demonstrate the Relationship between Dietary Protein Intake and Amino Acid Malabsorption.

Nutrients
2019

Structure and mechanism of the cation-chloride cotransporter NKCC1.

Nature
2019

Metabonomics of mice intestine in Codonopsis foetens induced apoptosis of intestine cancer cells.

Saudi journal of biological sciences
2019

L-Tryptophan represses persister formation via inhibiting bacterial motility and promoting antibiotics absorption.

Future microbiology
2019

Soybean glycinin decreased growth performance, impaired intestinal health, and amino acid absorption capacity of juvenile grass carp (Ctenopharyngodon idella).

Fish physiology and biochemistry
2019

Transcriptomic analysis of enteropathy in Zambian children with severe acute malnutrition.

EBioMedicine
2019

Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice.

American journal of physiology. Renal physiology
2019

N-Carbamylglutamate and l-Arginine Promote Intestinal Absorption of Amino Acids by Regulating the mTOR Signaling Pathway and Amino Acid and Peptide Transporters in Suckling Lambs with Intrauterine Growth Restriction.

The Journal of nutrition
2020

Bioavailability and metabolism of selected cocoa bioactive compounds: A comprehensive review.

Critical reviews in food science and nutrition
2019

[Elucidation of Disease Mechanisms Based on Transport Function at Tissue Barriers and Challenges in Drug Development].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
2019

A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody.

Cephalalgia : an international journal of headache
2020

Bacillus amyloliquefaciens Ameliorates H2O2-Induced Oxidative Damage by Regulating Transporters, Tight Junctions, and Apoptosis Gene Expression in Cell Line IPEC-1.

Probiotics and antimicrobial proteins
2019

Substitutions that lock and unlock the proton-coupled folate transporter (PCFT-SLC46A1) in an inward-open conformation.

The Journal of biological chemistry
2019

Effects of chronic stress on intestinal amino acid pathways.

Physiology & behavior
2019

Inhibition of Niemann-Pick C1-Like 1 by Ezetimibe Reduces Dietary 5β,6β-Epoxycholesterol Absorption in Rats.

Cardiovascular drugs and therapy
2018

Amino Acid Transport Across the Mammalian Intestine.

Comprehensive Physiology
2019

Gastrointestinal Malabsorption of Thyroxine.

Endocrine reviews
2018

Development of Biomarkers for Inhibition of SLC6A19 (B⁰AT1)-A Potential Target to Treat Metabolic Disorders.

International journal of molecular sciences
2018

Evaluation of the Mitra microsampling device for use with key urinary metabolites in patients with Alkaptonuria.

Bioanalysis
2019

Basolateral presence of the proinflammatory cytokine tumor necrosis factor -α and secretions from adipocytes and macrophages reduce intestinal sugar transport.

Journal of cellular physiology
2018

Cyclooxygenase pathway mediates the inhibition of Na-glutamine co-transporter B0AT1 in rabbit villus cells during chronic intestinal inflammation.

PloS one
2018

Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition.

BMB reports
2018

Inhibiting neutral amino acid transport for the treatment of phenylketonuria.

JCI insight
2018

Improving the diagnosis of cobalamin and related defects by genomic analysis, plus functional and structural assessment of novel variants.

Orphanet journal of rare diseases
2018

Cholera toxin inhibits SNX27-retromer-mediated delivery of cargo proteins to the plasma membrane.

Journal of cell science
2018

Adenosinergic signaling inhibits oxalate transport by human intestinal Caco2-BBE cells through the A2B adenosine receptor.

American journal of physiology. Cell physiology
2018

Scaling behavior of drug transport and absorption in in silico cerebral capillary networks.

PloS one
2019

Rabbit SLC15A1, SLC7A1 and SLC1A1 genes are affected by site of digestion, stage of development and dietary protein content.

Animal : an international journal of animal bioscience
2019

Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.

Journal of biomolecular structure & dynamics
2018

Proton Coupled Oligopeptide Transporter 1 (PepT1) Function, Regulation, and Influence on the Intestinal Homeostasis.

Comprehensive Physiology
2018

Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Comprehensive Physiology
2018

High-fat diet affects gut nutrients transporters in hypo and hyperthyroid mice by PPAR-a independent mechanism.

Life sciences
2018

Cooperation of Antiporter LAT2/CD98hc with Uniporter TAT1 for Renal Reabsorption of Neutral Amino Acids.

Journal of the American Society of Nephrology : JASN
2018

The Pharmabiotic Approach to Treat Hyperammonemia.

Nutrients
2018

Effects of dietary supplementation of arginine-silicate-inositol complex on absorption and metabolism of calcium of laying hens.

PloS one
2018

Hereditary folate malabsorption due to a mutation in the external gate of the proton-coupled folate transporter SLC46A1.

Blood advances
2018

Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application.

Molecular pharmaceutics
2017

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.

Molecules (Basel, Switzerland)
2018

Varying the ratio of Lys:Met while maintaining the ratios of Thr:Phe, Lys:Thr, Lys:His, and Lys:Val alters mammary cellular metabolites, mammalian target of rapamycin signaling, and gene transcription.

Journal of dairy science
2017

Interaction of Excitatory Amino Acid Transporters 1 - 3 (EAAT1, EAAT2, EAAT3) with N-Carbamoylglutamate and N-Acetylglutamate.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
2017

Effect of early weaning on the expression of excitatory amino acid transporter 1 in the jejunum and ileum of piglets.

Molecular medicine reports
2017

A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson's disease.

International journal of pharmaceutics
2017

Oxidative species-induced excitonic transport in tubulin aromatic networks: Potential implications for neurodegenerative disease.

Journal of photochemistry and photobiology. B, Biology
2017

Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression.

Theranostics
2017

Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide.

International journal of pharmaceutics
2017

Amino Acid Hydration Decreases Radiation-Induced Nausea in Mice: A Pica Model.

Advances in experimental medicine and biology
2017

Acute Neuroinflammation Promotes Cell Responses to 1800 MHz GSM Electromagnetic Fields in the Rat Cerebral Cortex.

Neurotoxicity research
2017

[Quantitative Targeted Absolute Proteomics (QTAP)-based Pharmacoproteomics: The Importance of International Collaboration].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
2018

Memory and Learning Dysfunction Following Copper Toxicity: Biochemical and Immunohistochemical Basis.

Molecular neurobiology
2017

A common NHE3 single-nucleotide polymorphism has normal function and sensitivity to regulatory ligands.

American journal of physiology. Gastrointestinal and liver physiology
2017

The Effect of Uremic Solutes on the Organic Cation Transporter 2.

Journal of pharmaceutical sciences
2017

Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2017

Riboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases.

Journal of clinical medicine
2017

[Influence of occupational aluminum exposure on cognitive function and glutamate receptor protein expression in workers].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases
2017

Hypoxia-inducible factor-1α activation improves renal oxygenation and mitochondrial function in early chronic kidney disease.

American journal of physiology. Renal physiology
2017

Phenylalanine isotope pulse method to measure effect of sepsis on protein breakdown and membrane transport in the pig.

American journal of physiology. Endocrinology and metabolism
2017

MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer.

EMBO reports
2017

Kinetics, subcellular localization, and contribution to parasite virulence of a Trypanosoma cruzi hybrid type A heme peroxidase (TcAPx-CcP).

Proceedings of the National Academy of Sciences of the United States of America
2017

Kidney Cadmium Toxicity, Diabetes and High Blood Pressure: The Perfect Storm.

The Tohoku journal of experimental medicine

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença do transporte de aminoácidos.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença do transporte de aminoácidos

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Comparative cytotoxicity of novel mercury species α-mercuri-acetaldehyde and α-mercuri-acetic acid versus methylmercury in SH-SY5Y cells.
    The Journal of toxicological sciences· 2026· PMID 41621859mais citado
  2. TMAO converts cytochrome c into a pro-apoptotic peroxidase by destabilizing the heme-Met80 ligation.
    Cellular and molecular biology (Noisy-le-Grand, France)· 2025· PMID 41456257mais citado
  3. Hartnup disease-causing SLC6A19 mutations lead to B0AT1 aberrant trafficking and ACE2 mis-localisation implicating the endoplasmic reticulum protein quality control.
    Frontiers in cell and developmental biology· 2025· PMID 40852587mais citado
  4. Acute MK-801 induces hyperactivity and changes spatio-temporal exploratory dynamics without disrupting homebase retention in adult zebrafish.
    Behavioural brain research· 2025· PMID 40759306mais citado
  5. Pitfalls in the Diagnosis of Wilson Disease.
    Current neurology and neuroscience reports· 2025· PMID 40504409mais citado
  6. Intestinal transport of organic food compounds and drugs: A scoping review on the alterations observed in chronic kidney disease.
    Clin Nutr ESPEN· 2024· PMID 39491666recente
  7. Sporisorium reilianum polysaccharides improve DSS-induced ulcerative colitis by regulating intestinal barrier function and metabolites.
    Int J Biol Macromol· 2024· PMID 38490380recente
  8. Rebalancing of mitochondrial homeostasis through an NAD(+)-SIRT1 pathway preserves intestinal barrier function in severe malnutrition.
    EBioMedicine· 2023· PMID 37738832recente
  9. Anaplasma phagocytophilum Hijacks Flotillin and NPC1 Complex To Acquire Intracellular Cholesterol for Proliferation, Which Can Be Inhibited with Ezetimibe.
    mBio· 2021· PMID 34544283recente
  10. Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption.
    CPT Pharmacometrics Syst Pharmacol· 2020· PMID 32977369recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79166(Orphanet)
  2. MONDO:0019216(MONDO)
  3. GARD:18948(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q471778(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença do transporte de aminoácidos
Compêndio · Raras BR

Doença do transporte de aminoácidos

ORPHA:79166 · MONDO:0019216
CID-10
E72.0 · Distúrbios do transporte de aminoácidos
CID-11
MedGen
UMLS
C0268641
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades